<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Antibiotic resistance,Articles with unsourced statements since July 2008,Articles with unsourced statements since March 2008,Articles with unsourced statements since December 2008,Articles needing additional references from January 2008,Articles with unsourced statements since February 2007,Articles with dead external links since June 2008,Fact,Pharmacology,2008,ABC transporters" />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Antibiotic_resistance&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=Antibiotic_resistance&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Antibiotic resistance - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Antibiotic_resistance";
		var wgTitle = "Antibiotic resistance";
		var wgAction = "view";
		var wgArticleId = "1914";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 281630346;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Antibiotic_resistance skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Antibiotic resistance</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<p><b>Antibiotic resistance</b> is the ability of a <a href="/wiki/Microorganism" title="Microorganism">microorganism</a> to withstand the effects of <a href="/wiki/Antibiotics" title="Antibiotics" class="mw-redirect">antibiotics</a>. It is a specific type of <a href="/wiki/Drug_resistance" title="Drug resistance">drug resistance</a>. Antibiotic resistance evolves via <a href="/wiki/Natural_selection" title="Natural selection">natural selection</a> acting upon random <a href="/wiki/Mutation" title="Mutation">mutation</a>, but it can also be engineered by applying an evolutionary stress on a population. Once such a <a href="/wiki/Gene" title="Gene">gene</a> is generated, bacteria can then transfer the genetic information in a horizontal fashion (between individuals) by <a href="/wiki/Plasmid" title="Plasmid">plasmid</a> exchange. If a bacterium carries several resistance genes, it is called <b>multiresistant</b> or, informally, a <b>superbug</b>. The term <b>antimicrobial resistance</b> is sometimes used to explicitly encompass organisms other than <a href="/wiki/Bacteria" title="Bacteria">bacteria</a>.</p>
<p>Antibiotic resistance can also be introduced artificially into a microorganism through <a href="/wiki/Transformation_(genetics)" title="Transformation (genetics)">transformation</a> protocols. This can aid in implanting artificial genes into the microorganism. If the resistance gene is linked with the gene to be implanted, the antibiotic can be used to kill off organisms that lack the new gene.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Causes_and_risk_factors"><span class="tocnumber">1</span> <span class="toctext">Causes and risk factors</span></a></li>
<li class="toclevel-1"><a href="#Mechanisms"><span class="tocnumber">2</span> <span class="toctext">Mechanisms</span></a></li>
<li class="toclevel-1"><a href="#Resistant_pathogens"><span class="tocnumber">3</span> <span class="toctext">Resistant pathogens</span></a>
<ul>
<li class="toclevel-2"><a href="#Staphylococcus_aureus"><span class="tocnumber">3.1</span> <span class="toctext">Staphylococcus aureus</span></a></li>
<li class="toclevel-2"><a href="#Streptococcus_and_Enterococcus"><span class="tocnumber">3.2</span> <span class="toctext">Streptococcus and Enterococcus</span></a></li>
<li class="toclevel-2"><a href="#Pseudomonas_aeruginosa"><span class="tocnumber">3.3</span> <span class="toctext">Pseudomonas aeruginosa</span></a></li>
<li class="toclevel-2"><a href="#Clostridium_difficile"><span class="tocnumber">3.4</span> <span class="toctext">Clostridium difficile</span></a></li>
<li class="toclevel-2"><a href="#Acinetobacter_baumannii"><span class="tocnumber">3.5</span> <span class="toctext">Acinetobacter baumannii</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Role_of_animals"><span class="tocnumber">4</span> <span class="toctext">Role of animals</span></a></li>
<li class="toclevel-1"><a href="#Alternatives"><span class="tocnumber">5</span> <span class="toctext">Alternatives</span></a>
<ul>
<li class="toclevel-2"><a href="#Prevention"><span class="tocnumber">5.1</span> <span class="toctext">Prevention</span></a></li>
<li class="toclevel-2"><a href="#Phage_therapy"><span class="tocnumber">5.2</span> <span class="toctext">Phage therapy</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Development_of_new_drugs"><span class="tocnumber">6</span> <span class="toctext">Development of new drugs</span></a></li>
<li class="toclevel-1"><a href="#Applications"><span class="tocnumber">7</span> <span class="toctext">Applications</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">8</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">9</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#Footnotes"><span class="tocnumber">10</span> <span class="toctext">Footnotes</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">11</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Causes_and_risk_factors" id="Causes_and_risk_factors"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Antibiotic_resistance&amp;action=edit&amp;section=1" title="Edit section: Causes and risk factors">edit</a>]</span> <span class="mw-headline">Causes and risk factors</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Antibiotic_resistance.svg" class="image" title="Schematic representation of how antibiotic resistance evolves via natural selection. The top section represents a population of bacteria before exposure to an antibiotic. The middle section shows the population directly after exposure, the phase in which selection took place. The last section shows the distribution of resistance in a new generation of bacteria. The legend indicates the resistance levels of individuals."><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/f/f6/Antibiotic_resistance.svg/180px-Antibiotic_resistance.svg.png" width="180" height="330" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Antibiotic_resistance.svg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Schematic representation of how antibiotic resistance evolves via natural selection. The top section represents a population of bacteria before exposure to an antibiotic. The middle section shows the population directly after exposure, the phase in which selection took place. The last section shows the distribution of resistance in a new generation of bacteria. The legend indicates the resistance levels of individuals.</div>
</div>
</div>
<p>Antibiotic resistance can be a result of <a href="/wiki/Horizontal_gene_transfer" title="Horizontal gene transfer">horizontal gene transfer</a><sup id="cite_ref-0" class="reference"><a href="#cite_note-0" title=""><span>[</span>1<span>]</span></a></sup>, and also of unlinked point mutations in the <a href="/wiki/Pathogen" title="Pathogen">pathogen</a> <a href="/wiki/Genome" title="Genome">genome</a> and a rate of about 1 in 10<sup>8</sup> per chromosomal replication. The antibiotic action against the pathogen can be seen as an environmental pressure; those bacteria which have a mutation allowing them to survive will live on to reproduce. They will then pass this trait to their offspring, which will result in a fully resistant colony.</p>
<p>Several studies have demonstrated that patterns of antibiotic usage greatly affect the number of resistant organisms which develop<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since July 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup>. Overuse of <a href="/wiki/Broad-spectrum_antibiotic" title="Broad-spectrum antibiotic">broad-spectrum antibiotics</a>, such as second- and third-generation <a href="/wiki/Cephalosporin" title="Cephalosporin">cephalosporins</a>, greatly hastens the development of <b><a href="/wiki/Methicillin" title="Methicillin" class="mw-redirect">methicillin</a></b> resistance. Other factors contributing towards resistance include incorrect diagnosis, unnecessary prescriptions, improper use of antibiotics by patients, the impregnation of household items and children's toys with low levels of antibiotics, and the administration of antibiotics by mouth in livestock for growth promotion.</p>
<p>Researchers have recently demonstrated the bacterial protein <a href="/wiki/LexA" title="LexA" class="mw-redirect">LexA</a> may play a key role in the acquisition of bacterial mutations.<sup id="cite_ref-pmid15869329_1-0" class="reference"><a href="#cite_note-pmid15869329-1" title=""><span>[</span>2<span>]</span></a></sup></p>
<p><a name="Mechanisms" id="Mechanisms"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Antibiotic_resistance&amp;action=edit&amp;section=2" title="Edit section: Mechanisms">edit</a>]</span> <span class="mw-headline">Mechanisms</span></h2>
<p>The four main mechanisms by which microorganisms exhibit resistance to antimicrobials are:</p>
<ol>
<li>Drug inactivation or modification: e.g. enzymatic deactivation of <a href="/wiki/Penicillin" title="Penicillin"><i>Penicillin</i> G</a> in some penicillin-resistant bacteria through the production of <a href="/wiki/Beta-lactamases" title="Beta-lactamases" class="mw-redirect">β-lactamases</a>.</li>
<li>Alteration of target site: e.g. alteration of <a href="/wiki/Penicillin_binding_protein" title="Penicillin binding protein" class="mw-redirect">PBP</a>—the binding target site of penicillins—in <a href="/wiki/MRSA" title="MRSA" class="mw-redirect">MRSA</a> and other penicillin-resistant bacteria.</li>
<li>Alteration of metabolic pathway: e.g. some <a href="/wiki/Sulfa_drugs" title="Sulfa drugs" class="mw-redirect">sulfonamide</a>-resistant bacteria do not require <a href="/wiki/Para-aminobenzoic_acid" title="Para-aminobenzoic acid" class="mw-redirect">para-aminobenzoic acid</a> (PABA), an important precursor for the synthesis of <a href="/wiki/Folic_acid" title="Folic acid">folic acid</a> and <a href="/wiki/Nucleic_acids" title="Nucleic acids" class="mw-redirect">nucleic acids</a> in bacteria inhibited by sulfonamides. Instead, like mammalian cells, they turn to utilizing preformed folic acid.</li>
<li>Reduced drug accumulation: by decreasing drug <a href="/wiki/Semipermeable_membrane" title="Semipermeable membrane">permeability</a> and/or increasing active <a href="/wiki/Efflux" title="Efflux" class="mw-redirect">efflux</a> (pumping out) of the drugs across the cell surface.<sup id="cite_ref-Ponte-SucreA_2-0" class="reference"><a href="#cite_note-Ponte-SucreA-2" title=""><span>[</span>3<span>]</span></a></sup></li>
</ol>
<p><a name="Resistant_pathogens" id="Resistant_pathogens"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Antibiotic_resistance&amp;action=edit&amp;section=3" title="Edit section: Resistant pathogens">edit</a>]</span> <span class="mw-headline">Resistant pathogens</span></h2>
<p><a name="Staphylococcus_aureus" id="Staphylococcus_aureus"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Antibiotic_resistance&amp;action=edit&amp;section=4" title="Edit section: Staphylococcus aureus">edit</a>]</span> <span class="mw-headline"><i>Staphylococcus aureus</i></span></h3>
<p><i><a href="/wiki/Staphylococcus_aureus" title="Staphylococcus aureus">Staphylococcus aureus</a></i> (colloquially known as "Staph aureus" or a <i>Staph infection</i>) is one of the major resistant pathogens. Found on the <a href="/wiki/Mucous_membranes" title="Mucous membranes" class="mw-redirect">mucous membranes</a> and the <a href="/wiki/Skin" title="Skin">skin</a> of around a third of the population, it is extremely adaptable to antibiotic pressure. It was the first bacterium in which <a href="/wiki/Penicillin" title="Penicillin">penicillin</a> resistance was found—in 1947, just four years after the drug started being mass-produced. <a href="/wiki/Methicillin" title="Methicillin" class="mw-redirect">Methicillin</a> was then the antibiotic of choice, but has since been replaced by <a href="/wiki/Oxacillin" title="Oxacillin">oxacillin</a> due to significant kidney toxicity. MRSA (<a href="/wiki/Methicillin-resistant_Staphylococcus_aureus" title="Methicillin-resistant Staphylococcus aureus">methicillin-resistant <i>Staphylococcus aureus</i></a>) was first detected in Britain in 1961 and is now "quite common" in hospitals. MRSA was responsible for 37% of fatal cases of <a href="/wiki/Blood_poisoning" title="Blood poisoning" class="mw-redirect">blood poisoning</a> in the <a href="/wiki/United_Kingdom" title="United Kingdom">UK</a> in 1999, up from 4% in 1991. Half of all <i>S. aureus</i> infections in the <a href="/wiki/United_States" title="United States">US</a> are resistant to penicillin, methicillin, <a href="/wiki/Tetracycline" title="Tetracycline">tetracycline</a> and <a href="/wiki/Erythromycin" title="Erythromycin">erythromycin</a>.</p>
<p>This left <a href="/wiki/Vancomycin" title="Vancomycin">vancomycin</a> as the only effective agent available at the time. However, strains with intermediate (4-8 ug/ml) levels of resistance, termed GISA (glycopeptide intermediate <i>Staphylococcus aureus</i>) or VISA (vancomycin intermediate <i>Staphylococcus aureus</i>), began appearing in the late 1990s. The first identified case was in Japan in 1996, and strains have since been found in hospitals in England, France and the US. The first documented strain with complete (&gt;16ug/ml) resistance to vancomycin, termed VRSA (<a href="/wiki/Vancomycin-resistant_Staphylococcus_aureus" title="Vancomycin-resistant Staphylococcus aureus">Vancomycin-resistant <i>Staphylococcus aureus</i></a>) appeared in the United States in 2002.</p>
<p>A <i>new</i> class of antibiotics, <a href="/wiki/Linezolid" title="Linezolid">oxazolidinones</a>, became available in the 1990s, and the first commercially available oxazolidinone, <a href="/wiki/Linezolid" title="Linezolid">linezolid</a>, is comparable to vancomycin in effectiveness against MRSA. Linezolid-resistance in <i><a href="/wiki/Staphylococcus_aureus" title="Staphylococcus aureus">Staphylococcus aureus</a></i> was reported in 2003.</p>
<p>CA-MRSA (Community-acquired MRSA) has now emerged as an epidemic that is responsible for rapidly progressive, fatal diseases including necrotizing pneumonia, severe sepsis and necrotizing fasciitis.<sup id="cite_ref-pmid17146447_3-0" class="reference"><a href="#cite_note-pmid17146447-3" title=""><span>[</span>4<span>]</span></a></sup> Methicillin-resistant <i><a href="/wiki/Staphylococcus_aureus" title="Staphylococcus aureus">Staphylococcus aureus</a></i> (<a href="/wiki/MRSA" title="MRSA" class="mw-redirect">MRSA</a>) is the most frequently identified antimicrobial drug-resistant pathogen in US hospitals. The <a href="/wiki/Epidemiology" title="Epidemiology">epidemiology</a> of infections caused by MRSA is rapidly changing. In the past 10 years, infections caused by this organism have emerged in the community. The 2 MRSA clones in the United States most closely associated with community outbreaks, <a href="/w/index.php?title=USA400&amp;action=edit&amp;redlink=1" class="new" title="USA400 (page does not exist)">USA400</a> (MW2 strain, ST1 lineage) and <a href="/wiki/USA300" title="USA300" class="mw-redirect">USA300</a>, often contain <a href="/wiki/Panton-Valentine_leukocidin" title="Panton-Valentine leukocidin">Panton-Valentine leukocidin</a> (PVL) genes and, more frequently, have been associated with skin and soft tissue infections. Outbreaks of community-associated (CA)-MRSA infections have been reported in correctional facilities, among athletic teams, among military recruits, in newborn nurseries, and among active <a href="/wiki/Homosexuality" title="Homosexuality">homosexual</a> men. CA-MRSA infections now appear to be endemic in many urban regions and cause most CA-S. aureus infections.<sup id="cite_ref-pmid17479885_4-0" class="reference"><a href="#cite_note-pmid17479885-4" title=""><span>[</span>5<span>]</span></a></sup></p>
<p><a name="Streptococcus_and_Enterococcus" id="Streptococcus_and_Enterococcus"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Antibiotic_resistance&amp;action=edit&amp;section=5" title="Edit section: Streptococcus and Enterococcus">edit</a>]</span> <span class="mw-headline"><i>Streptococcus</i> and <i>Enterococcus</i></span></h3>
<p><i><a href="/wiki/Streptococcus_pyogenes" title="Streptococcus pyogenes">Streptococcus pyogenes</a></i> (Group A Streptococcus: GAS) infections can usually be treated with many different antibiotics. Early treatment may reduce the risk of death from invasive group A streptococcal disease. However, even the best medical care does not prevent death in every case. For those with very severe illness, supportive care in an intensive care unit may be needed. For persons with necrotizing fasciitis, surgery often is needed to remove damaged tissue.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5" title=""><span>[</span>6<span>]</span></a></sup> Strains of <i>S. pyogenes</i> resistant to <a href="/wiki/Macrolide" title="Macrolide">macrolide</a> antibiotics have emerged, however all strains remain uniformly sensitive to <a href="/wiki/Penicillin" title="Penicillin">penicillin</a>.<sup id="cite_ref-pmid15109426_6-0" class="reference"><a href="#cite_note-pmid15109426-6" title=""><span>[</span>7<span>]</span></a></sup></p>
<p>Resistance of <i><a href="/wiki/Streptococcus_pneumoniae" title="Streptococcus pneumoniae">Streptococcus pneumoniae</a></i> to penicillin and other beta-lactams is increasing worldwide. The major mechanism of resistance involves the introduction of mutations in genes encoding penicillin-binding proteins. Selective pressure is thought to play an important role, and use of beta-lactam antibiotics has been implicated as a risk factor for infection and colonization. Streptococcus pneumoniae is responsible for <a href="/wiki/Pneumonia" title="Pneumonia">pneumonia</a>, <a href="/wiki/Bacteremia" title="Bacteremia">bacteremia</a>, <a href="/wiki/Otitis_media" title="Otitis media">otitis media</a>, <a href="/wiki/Meningitis" title="Meningitis">meningitis</a>, <a href="/wiki/Sinusitis" title="Sinusitis">sinusitis</a>, <a href="/wiki/Peritonitis" title="Peritonitis">peritonitis</a> and <a href="/wiki/Arthritis" title="Arthritis">arthritis</a>.<sup id="cite_ref-pmid15109426_6-1" class="reference"><a href="#cite_note-pmid15109426-6" title=""><span>[</span>7<span>]</span></a></sup></p>
<p>Penicillin-resistant <a href="/wiki/Pneumonia" title="Pneumonia">pneumonia</a> caused by <i><a href="/wiki/Streptococcus_pneumoniae" title="Streptococcus pneumoniae">Streptococcus pneumoniae</a></i> (commonly known as <i>pneumococcus</i>), was first detected in 1967, as was penicillin-resistant <a href="/wiki/Gonorrhea" title="Gonorrhea">gonorrhea</a>. Resistance to penicillin substitutes is also known as beyond <i>S. aureus</i>. By 1993 <i><a href="/wiki/Escherichia_coli" title="Escherichia coli">Escherichia coli</a></i> was resistant to five <a href="/wiki/Quinolones" title="Quinolones" class="mw-redirect">fluoroquinolone</a> variants. <i><a href="/wiki/Mycobacterium_tuberculosis" title="Mycobacterium tuberculosis">Mycobacterium tuberculosis</a></i> is commonly resistant to <a href="/wiki/Isoniazid" title="Isoniazid">isoniazid</a> and <a href="/wiki/Rifampin" title="Rifampin" class="mw-redirect">rifampin</a> and sometimes universally resistant to the common treatments. Other pathogens showing some resistance include <i><a href="/wiki/Salmonella" title="Salmonella">Salmonella</a></i>, <i><a href="/wiki/Campylobacter" title="Campylobacter">Campylobacter</a></i>, and <i><a href="/wiki/Streptococci" title="Streptococci" class="mw-redirect">Streptococci</a></i>.</p>
<p><i><a href="/wiki/Enterococcus" title="Enterococcus">Enterococcus faecium</a></i> is another superbug found in hospitals. <a href="/w/index.php?title=Penicillin-Resistant_Enterococcus&amp;action=edit&amp;redlink=1" class="new" title="Penicillin-Resistant Enterococcus (page does not exist)">Penicillin-Resistant Enterococcus</a> was seen in 1983, <a href="/wiki/Vancomycin-resistant_enterococcus" title="Vancomycin-resistant enterococcus">vancomycin-resistant enterococcus</a> (VRE) in 1987, and <a href="/w/index.php?title=Linezolid-Resistant_Enterococcus&amp;action=edit&amp;redlink=1" class="new" title="Linezolid-Resistant Enterococcus (page does not exist)">Linezolid-Resistant Enterococcus</a> (LRE) in the late 1990s.</p>
<p><a name="Pseudomonas_aeruginosa" id="Pseudomonas_aeruginosa"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Antibiotic_resistance&amp;action=edit&amp;section=6" title="Edit section: Pseudomonas aeruginosa">edit</a>]</span> <span class="mw-headline"><i>Pseudomonas aeruginosa</i></span></h3>
<p><i><a href="/wiki/Pseudomonas_aeruginosa" title="Pseudomonas aeruginosa">Pseudomonas aeruginosa</a></i> is a highly prelevant <a href="/wiki/Opportunistic_pathogen" title="Opportunistic pathogen" class="mw-redirect">opportunistic pathogen</a>. One of the most worrisome characteristics of <i><a href="/wiki/P._aeruginosa" title="P. aeruginosa" class="mw-redirect">P. aeruginosa</a></i> consists in its low <a href="/wiki/Antibiotic" title="Antibiotic">antibiotic</a> susceptibility. This low susceptibility is attributable to a concerted action of <a href="/wiki/Efflux_(microbiology)" title="Efflux (microbiology)">multidrug efflux pumps</a> with chromosomally-encoded antibiotic resistance genes and the low permeability of the bacterial cellular envelopes. Besides intrinsic resistance, <i>P. aeruginosa</i> easily develop acquired resistance either by <a href="/wiki/Mutation" title="Mutation">mutation</a> in chromosomally-encoded genes, or by the horizontal gene transfer of antibiotic resistance determinants. Development of <a href="/wiki/Multidrug_resistance" title="Multidrug resistance" class="mw-redirect">multidrug resistance</a> by <i>P. aeruginosa</i> isolates requires several different genetic events that include acquisition of different mutations and/or horizontal transfer of antibiotic resistance genes. Hypermutation favours the selection of mutation-driven antibiotic resistance in <i>P. aeruginosa</i> strains producing chronic infections, whereas the clustering of several different antibiotic resistance genes in <a href="/wiki/Integron" title="Integron">integrons</a> favours the concerted acquisition of antibiotic resistance determinants. Some recent studies have shown that phenotypic resistance associated to <a href="/wiki/Biofilm" title="Biofilm">biofilm</a> formation or to the emergence of small-colony-variants may be important in the response of <i>P. aeruginosa</i> populations to <a href="/wiki/Antibiotic" title="Antibiotic">antibiotics</a> treatment.<sup id="cite_ref-Cornelis_7-0" class="reference"><a href="#cite_note-Cornelis-7" title=""><span>[</span>8<span>]</span></a></sup></p>
<p><a name="Clostridium_difficile" id="Clostridium_difficile"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Antibiotic_resistance&amp;action=edit&amp;section=7" title="Edit section: Clostridium difficile">edit</a>]</span> <span class="mw-headline"><i>Clostridium difficile</i></span></h3>
<p><i><a href="/wiki/Clostridium_difficile" title="Clostridium difficile">Clostridium difficile</a></i> is a nosocomial pathogen that causes diarrheal disease in hospitals world wide.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8" title=""><span>[</span>9<span>]</span></a></sup><sup id="cite_ref-McDonald_2005_9-0" class="reference"><a href="#cite_note-McDonald_2005-9" title=""><span>[</span>10<span>]</span></a></sup> <a href="/wiki/Clindamycin" title="Clindamycin">Clindamycin</a>-resistant <i>C. difficile</i> was reported as the causative agent of large outbreaks of diarrheal disease in hospitals in New York, Arizona, Florida and Massachusetts between 1989 and 1992.<sup id="cite_ref-Johnson1999_10-0" class="reference"><a href="#cite_note-Johnson1999-10" title=""><span>[</span>11<span>]</span></a></sup> Geographically dispersed outbreaks of <i>C. difficile</i> strains resistant to <a href="/wiki/Fluoroquinolone" title="Fluoroquinolone" class="mw-redirect">fluoroquinolone</a> antibiotics, such as <a href="/wiki/Cipro" title="Cipro" class="mw-redirect">Cipro</a> (ciprofloxacin) and <a href="/wiki/Levaquin" title="Levaquin" class="mw-redirect">Levaquin</a> (levofloxacin), were also reported in North America in 2005.<sup id="cite_ref-Loo_2005_11-0" class="reference"><a href="#cite_note-Loo_2005-11" title=""><span>[</span>12<span>]</span></a></sup></p>
<p><a name="Acinetobacter_baumannii" id="Acinetobacter_baumannii"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Antibiotic_resistance&amp;action=edit&amp;section=8" title="Edit section: Acinetobacter baumannii">edit</a>]</span> <span class="mw-headline"><i>Acinetobacter baumannii</i></span></h3>
<p>On the 5th November 2004 , the <a href="/wiki/Centers_for_Disease_Control_and_Prevention" title="Centers for Disease Control and Prevention">Centers for Disease Control and Prevention</a> (CDC) reported an increasing number of <i><a href="/wiki/Acinetobacter_baumannii" title="Acinetobacter baumannii">Acinetobacter baumannii</a></i> bloodstream infections in patients at military medical facilities in which service members injured in the <a href="/wiki/Iraq" title="Iraq">Iraq</a>/<a href="/wiki/Kuwait" title="Kuwait">Kuwait</a> region during <a href="/wiki/Iraq_war" title="Iraq war" class="mw-redirect">Operation Iraqi Freedom</a> and in <a href="/wiki/Afghanistan" title="Afghanistan">Afghanistan</a> during <a href="/wiki/Operation_Enduring_Freedom" title="Operation Enduring Freedom">Operation Enduring Freedom</a> were treated. Most of these showed <a href="/wiki/Multidrug_resistance" title="Multidrug resistance" class="mw-redirect">multidrug resistance</a> (MRAB), with a few isolates resistant to all drugs tested.<sup id="cite_ref-pmid15549020_12-0" class="reference"><a href="#cite_note-pmid15549020-12" title=""><span>[</span>13<span>]</span></a></sup><sup id="cite_ref-13" class="reference"><a href="#cite_note-13" title=""><span>[</span>14<span>]</span></a></sup></p>
<p><a name="Role_of_animals" id="Role_of_animals"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Antibiotic_resistance&amp;action=edit&amp;section=9" title="Edit section: Role of animals">edit</a>]</span> <span class="mw-headline">Role of animals</span></h2>
<p><a href="/wiki/Methicillin_Resistant_Staphylococcus_Aureus" title="Methicillin Resistant Staphylococcus Aureus" class="mw-redirect">Methicillin Resistant Staphylococcus Aureus</a> (MRSA) is acknowledged to be a human <a href="/wiki/Commensal" title="Commensal" class="mw-redirect">commensal</a> and <a href="/wiki/Pathogen" title="Pathogen">pathogen</a>. MRSA has been found in cats, dogs and horses, where it can cause the same problems as it does in humans. Owners can transfer the organism to their pets and vice-versa, and MRSA in animals is generally believed to be derived from humans.</p>
<table class="metadata plainlinks ambox ambox-content" style="">
<tr>
<td class="mbox-image">
<div style="width: 52px;"><a href="/wiki/File:Unbalanced_scales.svg" class="image" title="Unbalanced scales.svg"><img alt="" src="http://upload.wikimedia.org/wikipedia/en/thumb/f/fe/Unbalanced_scales.svg/45px-Unbalanced_scales.svg.png" width="45" height="40" border="0" /></a></div>
</td>
<td class="mbox-text" style="">This article <b>may be inaccurate or <a href="/wiki/Wikipedia:Neutral_point_of_view#Undue_weight" title="Wikipedia:Neutral point of view">unbalanced</a> in favor of certain viewpoints</b>. Please <a href="http://en.wikipedia.org/w/index.php?title=Antibiotic_resistance&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Antibiotic_resistance&amp;action=edit" rel="nofollow">improve the article</a> by adding information on neglected viewpoints, or discuss the issue on the <a href="/wiki/Talk:Antibiotic_resistance" title="Talk:Antibiotic resistance">talk page</a>.</td>
</tr>
</table>
<p>The <a href="/wiki/United_States_Food_and_Drug_Administration" title="United States Food and Drug Administration" class="mw-redirect">United States Food and Drug Administration</a> has responsibility for determining the safety of food as well as drugs. Drugs are frequently used for animals the same way they are used in people – to treat illness and improve the health of the animals. Drugs are used in animals that are used as human food, such as cows, pigs, chickens, fish, etc., and these drugs can affect the safety of the meat, milk, and eggs produced from those animals. Therefore, FDA has the responsibility to review drugs intended for use in food animals, and to be sure that the use of the drugs does not result in harmful residues in food or create resistant pathogens that can harm human health. For example, farm animals, particularly pigs, are believed to be able to infect people with MRSA.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14" title=""><span>[</span>15<span>]</span></a></sup> In 1951, the FDA approved the use of antibiotics in animal feed without a veterinary medical prescription; Concerns about resistance have been revisited several times since then, and most antimicrobials have not been shown to be a hazard. Europe quickly followed suit. As the spread of drug-resistant bacteria became a concern, countries began questioning the practice. In 1969, Britain issued the Swann Report<sup id="cite_ref-15" class="reference"><a href="#cite_note-15" title=""><span>[</span>16<span>]</span></a></sup>, which recommended that human therapeutic antibiotics be banned from being used as growth promoters in agriculture. The report was largely ignored. It's pointed out by industry, that most of the routine feed drugs are either not used in human medicine, or are older compounds that have long been superseded by later-generation drugs.</p>
<p>Nearly 30 years later, the World Health Organization concluded that antibiotics as growth promoters in animal feeds should be prohibited (in the absence of risk assessments). And in 1998, European Union health ministers voted to ban four antibiotics widely used to promote animal growth (despite their scientific panel's recommendations). Regulation banning the use of antibiotics in European feed, with the exception of two antibiotics in poultry feeds, became effective in 2006.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16" title=""><span>[</span>17<span>]</span></a></sup> With good animal husbandry and hygiene, there shouldn't be adverse effects, health-wise or production-wise, from not using antibiotics in animal feed. In Scandinavia, there's evidence that the ban has led to a lower prevalence of antimicrobial resistance in (non-hazardous) animal bacterial populations.<sup id="cite_ref-17" class="reference"><a href="#cite_note-17" title=""><span>[</span>18<span>]</span></a></sup> Meanwhile, in the poultry industry, the ban hasn't had a deleterious effect. Economic performance in poultry production wasn't adversely affected either. Whether banning feed drugs has had any actual benefit to public health has been the topic of several reviews. Foodborne incidence and resistance patterns in humans, have not declined in countries featuring animal bans, in fact some have increased. Meanwhile, there were higher mortality in swine populations following bans. the "success" of Scandinavain and EU bans is therefore highly questionable as a useful policy, according to several published reviews. In the United States, antibiotic use in animal feeds remains controversial, due to a well-financed anti-agricultural campaign. The FDA first called for restrictions in 1997<sup id="cite_ref-18" class="reference"><a href="#cite_note-18" title=""><span>[</span>19<span>]</span></a></sup>, which generated many studies and reports on the issue. In 1980, the Institute of Medicine reviewed the subject and recommended that more studies be conducted.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19" title=""><span>[</span>20<span>]</span></a></sup> In 1999, the General Accounting Office (GAO) also concluded that the evidence was inconclusive. A follow-up 2004 GAO study<sup id="cite_ref-20" class="reference"><a href="#cite_note-20" title=""><span>[</span>21<span>]</span></a></sup> found that evidence existed of antibiotic-resistant bacteria being transferred from animals to humans. But since federal agencies don't collect data on antibiotic use in animals, conclusions on the potential impact on human health couldn't be made. Therefore, antibiotics are still used in U.S. animal feed--along with evidence of other worrisome ingredients.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21" title=""><span>[</span>22<span>]</span></a></sup><sup id="cite_ref-22" class="reference"><a href="#cite_note-22" title=""><span>[</span>23<span>]</span></a></sup></p>
<p>Growing U.S. consumer concern about using antibiotics in animal feed has led to a niche market of "antibiotic-free" animal products, but this small market is unlikely to change entrenched industry-wide practices.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23" title=""><span>[</span>24<span>]</span></a></sup> Within FDA, the animal drug review duties have been assigned to one of the Agency’s operating units, the <a href="/wiki/Center_for_Veterinary_Medicine" title="Center for Veterinary Medicine">Center for Veterinary Medicine</a>. Their guidance is used to evaluate all types and uses of antimicrobials, including what some refer to as subtherapeutic use. Although that term has not been defined by regulation, it describes the use of a product to boost an animal’s ability to grow and produce more food, instead of treating or preventing an infectious disease. It could also be used to evaluate antimicrobials if they are used for growth promotion, and for antimicrobials that are products of genetic engineering. Animals that we use to produce food for human consumption, including cows (for beef and milk production), pigs, chickens, turkeys, fish, and sheep. Antimicrobials are used to cause animals to increase production of food. Antimicrobials are used in feeds for some species, and the animals fed the antimicrobial feeds often grow faster while consuming less feed than animals not given antimicrobials in feed. In addition to determining whether the use of a drug would result in residues left in the meat, milk, or eggs, FDA must ensure that the use of antimicrobials in food-producing animals does not lead to the development of resistant bacteria that can become a public health concern. This document is one way that drug sponsors can submit information that address the issue of the microbial safety of antimicrobial new animal drugs. A sponsor is free to use other scientifically valid approaches to demonstrate the safety of their proposed product. CVM first said in December 1999 that it would consider the question of the fostering of antimicrobial resistance when reviewing antimicrobials for use in animals. That announcement was followed a year later with what was called FDA’s “Framework Document,” which first described the FDA’s plan to use risk assessments of the development of antimicrobial resistance in determining the safety of antimicrobials for food-producing animals. The guidance document was first published as a draft in September 2002, to allow the scientific community to comment on the concept and on the science FDA used to develop the guidance document. The FDA allows the use of antimicrobials because they are a valuable tool that veterinarians can use to treat sick animals, and so livestock producers can use antimicrobials to produce meat, milk, and eggs more efficiently.</p>
<p>In 2001, the Union of Concerned Scientists estimated that greater than 70% of the antibiotics used in the US are given to food animals (e.g. chickens, pigs and cattle) in the absence of disease<sup id="cite_ref-24" class="reference"><a href="#cite_note-24" title=""><span>[</span>25<span>]</span></a></sup>. This 2001 report, however, has been shown to over-estimate animal usage rates. Antibiotic use in food animal production has been associated with the emergence of antibiotic-resistant strains of bacteria including <a href="/wiki/Salmonella" title="Salmonella">Salmonella</a>, <a href="/wiki/Campylobacter" title="Campylobacter">Campylobacter</a>, <a href="/wiki/Escherichia_coli" title="Escherichia coli">Escherichia coli</a> and <a href="/wiki/Enterococcus" title="Enterococcus">Enterococcus</a>, among others. There is substantial evidence from the US and European Union that these resistant bacteria cause antibiotic-resistant infections in humans<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since March 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup>. The <a href="/wiki/American_Society_for_Microbiology" title="American Society for Microbiology">American Society for Microbiology</a> (ASM)<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since March 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup>, the <a href="/wiki/American_Public_Health_Association" title="American Public Health Association">American Public Health Association</a> (APHA) and the <a href="/wiki/American_Medical_Association" title="American Medical Association">American Medical Association</a> (AMA) have called for substantial restrictions on antibiotic use in food animal production including an end to all "non-therapeutic" uses. The food animal and pharmaceutical industries have fought hard to prevent new regulations that would limit the use of antibiotics in food animal production, pointing out that while concerns exist, risk assessments and actual data have demonstrated little to no risk in this area. For example, in 2000 the <a href="/wiki/US_Food_and_Drug_Administration" title="US Food and Drug Administration" class="mw-redirect">US Food and Drug Administration</a> (FDA) announced their intention to rescind approval for <a href="/wiki/Fluoroquinolone" title="Fluoroquinolone" class="mw-redirect">fluoroquinolone</a> use in poultry production because of substantial evidence linking it to the emergence of fluoroquinolone resistant Campylobacter infections in humans. The final decision to ban fluoroquinolones from use in poultry production was not made until 5 years later because of challenges from the food animal and pharmaceutical industries.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25" title=""><span>[</span>26<span>]</span></a></sup> Today, there are two federal bills (S. 549<sup id="cite_ref-26" class="reference"><a href="#cite_note-26" title=""><span>[</span>27<span>]</span></a></sup> and H.R. 962<sup id="cite_ref-27" class="reference"><a href="#cite_note-27" title=""><span>[</span>28<span>]</span></a></sup>) aimed at phasing out "non-therapeutic" antibiotics in US food animal production. These bills are nominally endorsed by many public health and medical organizations including the <a href="/wiki/American_Nurses_Association" title="American Nurses Association">American Nurses Association</a> (ANA))<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since December 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup>, the <a href="/wiki/American_Academy_of_Pediatrics" title="American Academy of Pediatrics">American Academy of Pediatrics</a> (AAP)<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since December 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup>, and the <a href="/wiki/American_Public_Health_Association" title="American Public Health Association">American Public Health Association</a> (APHA)<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since December 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup>. Other professional groups, notably animal science, food science, veterinary, and industry groups do not support this legislation, however, pointing out that current uses are not shown to be hazardous and have legitimate disease prevention roles.</p>
<p><a name="Alternatives" id="Alternatives"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Antibiotic_resistance&amp;action=edit&amp;section=10" title="Edit section: Alternatives">edit</a>]</span> <span class="mw-headline">Alternatives</span></h2>
<p><a name="Prevention" id="Prevention"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Antibiotic_resistance&amp;action=edit&amp;section=11" title="Edit section: Prevention">edit</a>]</span> <span class="mw-headline">Prevention</span></h3>
<p>Rational use of <a href="/wiki/Antibiotics" title="Antibiotics" class="mw-redirect">antibiotics</a> may reduce the chances of development of opportunistic infection by antibiotic-resistant bacteria due to dysbacteriosis. In one study the use of fluoroquinolones are clearly associated with <i><a href="/wiki/Clostridium_difficile" title="Clostridium difficile">Clostridium difficile</a></i> infection, which is a leading cause of <a href="/wiki/Nosocomial" title="Nosocomial" class="mw-redirect">nosocomial</a> <a href="/wiki/Diarrhea" title="Diarrhea">diarrhea</a> in the United States,<sup id="cite_ref-pmid12781017_28-0" class="reference"><a href="#cite_note-pmid12781017-28" title=""><span>[</span>29<span>]</span></a></sup> and a major cause of death, worldwide.<sup id="cite_ref-pmid9866738_29-0" class="reference"><a href="#cite_note-pmid9866738-29" title=""><span>[</span>30<span>]</span></a></sup></p>
<p><a href="/wiki/Vaccine" title="Vaccine">Vaccines</a> do not suffer the problem of resistance because a vaccine enhances the body's natural defenses, while an antibiotic operates separately from the body's normal defenses. Nevertheless, new strains may <a href="/wiki/Evolution" title="Evolution">evolve</a> that escape immunity induced by vaccines.</p>
<p>While theoretically promising, anti-staphylococcal vaccines have shown limited efficacy, because of immunological variation between <i>Staphylococcus</i> species, and the limited duration of effectiveness of the antibodies produced. Development and testing of more effective vaccines is under way.</p>
<p><a name="Phage_therapy" id="Phage_therapy"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Antibiotic_resistance&amp;action=edit&amp;section=12" title="Edit section: Phage therapy">edit</a>]</span> <span class="mw-headline">Phage therapy</span></h3>
<p><a href="/wiki/Phage_therapy" title="Phage therapy">Phage therapy</a>, an approach that has been extensively researched and utilized as a therapeutic agent for over 60 years, especially in the <a href="/wiki/Soviet_Union" title="Soviet Union">Soviet Union</a>, is an alternative that might help with the problem of resistance. Phage Therapy was widely used in the United States until the discovery of antibiotics, in the early 1940s. Bacteriophages or "phages" are viruses that invade bacterial cells and, in the case of lytic phages, disrupt bacterial metabolism and cause the bacterium to <a href="/wiki/Lysis" title="Lysis">lyse</a>. Phage Therapy is the therapeutic use of lytic <a href="/wiki/Bacteriophages" title="Bacteriophages" class="mw-redirect">bacteriophages</a> to treat <a href="/wiki/Pathogenic" title="Pathogenic" class="mw-redirect">pathogenic</a> bacterial infections.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30" title=""><span>[</span>31<span>]</span></a></sup><sup id="cite_ref-31" class="reference"><a href="#cite_note-31" title=""><span>[</span>32<span>]</span></a></sup><sup id="cite_ref-32" class="reference"><a href="#cite_note-32" title=""><span>[</span>33<span>]</span></a></sup></p>
<p>Bacteriophage therapy is an important alternative to antibiotics in the current era of multidrug resistant pathogens. A review of studies that dealt with the therapeutic use of phages from 1966–1996 and few latest ongoing phage therapy projects via internet showed: phages were used topically, orally or systemically in Polish and Soviet studies. The success rate found in these studies was 80–95% with few gastrointestinal or allergic side effects. British studies also demonstrated significant efficacy of phages against <i><a href="/wiki/Escherichia_coli" title="Escherichia coli">Escherichia coli</a></i>, <i><a href="/wiki/Acinetobacter" title="Acinetobacter">Acinetobacter</a></i> spp., <i><a href="/wiki/Pseudomonas" title="Pseudomonas">Pseudomonas</a></i> spp and <i><a href="/wiki/Staphylococcus_aureus" title="Staphylococcus aureus">Staphylococcus aureus</a></i>. US studies dealt with improving the bioavailability of phage. Phage therapy may prove as an important alternative to antibiotics for treating multidrug resistant pathogens.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33" title=""><span>[</span>34<span>]</span></a></sup> <sup id="cite_ref-McGrath_34-0" class="reference"><a href="#cite_note-McGrath-34" title=""><span>[</span>35<span>]</span></a></sup></p>
<p><a name="Development_of_new_drugs" id="Development_of_new_drugs"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Antibiotic_resistance&amp;action=edit&amp;section=13" title="Edit section: Development of new drugs">edit</a>]</span> <span class="mw-headline">Development of new drugs</span></h2>
<table class="metadata plainlinks ambox ambox-content" style="">
<tr>
<td class="mbox-image">
<div style="width: 52px;"><a href="/wiki/File:Question_book-new.svg" class="image" title="Question book-new.svg"><img alt="" src="http://upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png" width="50" height="39" border="0" /></a></div>
</td>
<td class="mbox-text" style="">This article <b>needs additional <a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources">citations</a> for <a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability">verification</a>.</b> Please help <a href="http://en.wikipedia.org/w/index.php?title=Antibiotic_resistance&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Antibiotic_resistance&amp;action=edit" rel="nofollow">improve this article</a> by adding <a href="/wiki/Wikipedia:Reliable_sources" title="Wikipedia:Reliable sources">reliable references</a> (ideally, using <i><a href="/wiki/Wikipedia:Footnotes" title="Wikipedia:Footnotes">inline citations</a></i>). Unsourced material may be <a href="/wiki/Template:Fact" title="Template:Fact">challenged</a> and <a href="/wiki/Wikipedia:BURDEN" title="Wikipedia:BURDEN" class="mw-redirect">removed</a>. <small><i>(January 2008)</i></small></td>
</tr>
</table>
<p>Until recently, <a href="/wiki/Research_and_development" title="Research and development">research and development</a> (R&amp;D) efforts have provided new drugs in time to treat bacteria that became resistant to older antibiotics. That is no longer the case. The potential crisis at hand is the result of a marked decrease in industry R&amp;D, government inaction, and the increasing prevalence of resistant bacteria. Infectious disease physicians are alarmed by the prospect that effective antibiotics may not be available to treat seriously ill patients in the near future.</p>
<p>The pipeline of new antibiotics is drying up. Major <a href="/wiki/List_of_pharmaceutical_companies" title="List of pharmaceutical companies">pharmaceutical companies</a> are losing interest in the antibiotics market because these drugs may not be as profitable as drugs that treat chronic (long-term) conditions and lifestyle issues.<sup id="cite_ref-35" class="reference"><a href="#cite_note-35" title=""><span>[</span>36<span>]</span></a></sup></p>
<p>The resistance problem demands that a renewed effort be made to seek antibacterial agents effective against pathogenic bacteria resistant to current antibiotics. One of the possible strategies towards this objective is the rational localization of <a href="/wiki/Bioactive" title="Bioactive" class="mw-redirect">bioactive</a> <a href="/wiki/Phytochemical" title="Phytochemical">phytochemicals</a>. Plants have an almost limitless ability to synthesize <a href="/wiki/Aromatic" title="Aromatic" class="mw-redirect">aromatic</a> substances, most of which are <a href="/wiki/Phenol" title="Phenol">phenols</a> or their oxygen-substituted derivatives such as <a href="/wiki/Tannin" title="Tannin">tannins</a>. Most are secondary <a href="/wiki/Metabolite" title="Metabolite">metabolites</a>, of which at least 12,000 have been isolated, a number estimated to be less than 10% of the total<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since February 2007" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup>. In many cases, these substances serve as plant defense mechanisms against <a href="/wiki/Predation" title="Predation">predation</a> by <a href="/wiki/Microorganism" title="Microorganism">microorganisms</a>, <a href="/wiki/Insect" title="Insect">insects</a>, and <a href="/wiki/Herbivore" title="Herbivore">herbivores</a>. Many of the herbs and spices used by humans to season food yield useful medicinal compounds including those having antibacterial activity.<sup id="cite_ref-pmid15831135_36-0" class="reference"><a href="#cite_note-pmid15831135-36" title=""><span>[</span>37<span>]</span></a></sup><sup id="cite_ref-pmid12872531_37-0" class="reference"><a href="#cite_note-pmid12872531-37" title=""><span>[</span>38<span>]</span></a></sup><sup id="cite_ref-pmid12410554_38-0" class="reference"><a href="#cite_note-pmid12410554-38" title=""><span>[</span>39<span>]</span></a></sup></p>
<p>Traditional healers have long used plants to prevent or cure infectious conditions. Many of these plants have been investigated scientifically for antimicrobial activity and a large number of plant products have been shown to inhibit growth of pathogenic bacteria. A number of these agents appear to have structures and modes of action that are distinct from those of the antibiotics in current use, suggesting that <a href="/wiki/Cross-resistance" title="Cross-resistance">cross-resistance</a> with agents already in use may be minimal. For example the combination of <a href="/w/index.php?title=5%27-methoxyhydnocarpine&amp;action=edit&amp;redlink=1" class="new" title="5'-methoxyhydnocarpine (page does not exist)">5'-methoxyhydnocarpine</a> and <a href="/wiki/Berberine" title="Berberine">berberine</a> in herbs like <a href="/wiki/Hydrastis_canadensis" title="Hydrastis canadensis" class="mw-redirect">Hydrastis canadensis</a> and <a href="/wiki/Berberis_vulgaris" title="Berberis vulgaris">Berberis vulgaris</a> can block the MDR-pumps that cause multidrug resistance. This has been shown for <a href="/wiki/Staphylococcus_aureus" title="Staphylococcus aureus">Staphylococcus aureus</a>.<sup id="cite_ref-pmid10677479_39-0" class="reference"><a href="#cite_note-pmid10677479-39" title=""><span>[</span>40<span>]</span></a></sup></p>
<p><a href="/wiki/Archaeocin" title="Archaeocin">Archaeocins</a> is the name given to a new class of potentially useful antibiotics that are derived from the <a href="/wiki/Archaea" title="Archaea">Archaea</a> group of organisms. Eight archaeocins have been partially or fully characterized, but hundreds of archaeocins are believed to exist, especially within the <a href="/wiki/Archaea" title="Archaea">haloarchaea</a>. The prevalence of archaeocins is unknown simply because no one has looked for them. The discovery of new archaeocins hinges on recovery and cultivation of archaeal organisms from the environment. For example, samples from a novel hypersaline field site, Wilson Hot Springs, recovered 350 halophilic organisms; preliminary analysis of 75 isolates showed that 48 were archaeal and 27 were bacterial.<sup id="cite_ref-Shand_40-0" class="reference"><a href="#cite_note-Shand-40" title=""><span>[</span>41<span>]</span></a></sup></p>
<p>In research published online on <span class="mw-formatted-date" title="2008-10-22"><span class="mw-formatted-date" title="10-22"><a href="/wiki/October_22" title="October 22">October 22</a></span>, <a href="/wiki/2008" title="2008">2008</a></span> in Nature, a team of scientists pinpointed the place on bacteria where the antibiotic <a href="/wiki/Myxopyronin" title="Myxopyronin">myxopyronin</a> launches its attack, and why that attack is successful. The myxopyronin binds to and inhibits the crucial bacterial enzyme, <a href="/wiki/RNA_polymerase" title="RNA polymerase">RNA polymerase</a>. The myxopyronin changes the structure of the switch-2 segment of the enzyme, inhibiting its function of reading and transmitting DNA code. This prevents RNA polymerase from delivering genetic information to the <a href="/wiki/Ribosomes" title="Ribosomes" class="mw-redirect">ribosomes</a>, causing the bacteria to die.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41" title=""><span>[</span>42<span>]</span></a></sup><sup id="cite_ref-42" class="reference"><a href="#cite_note-42" title=""><span>[</span>43<span>]</span></a></sup></p>
<p>One of the major causes of antibiotic resistance is the decrease of effective drug concentrations at their target place, due to the increased action of <a href="/wiki/ABC_transporters" title="ABC transporters" class="mw-redirect">ABC transporters</a>. Since ABC transporter blockers can be used in combination with current drugs to increase their effective intracellular concentration, the possible impact of ABC transporter inhibitors is of great clinical interest. ABC transporter blockers that may be useful to increase the efficacy of current drugs have entered clinical trials and are available to be used in therapeutic regimes.<sup id="cite_ref-Ponte-SucreA_2-1" class="reference"><a href="#cite_note-Ponte-SucreA-2" title=""><span>[</span>3<span>]</span></a></sup></p>
<p><a name="Applications" id="Applications"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Antibiotic_resistance&amp;action=edit&amp;section=14" title="Edit section: Applications">edit</a>]</span> <span class="mw-headline">Applications</span></h2>
<p>Antibiotic resistance is an important tool for <a href="/wiki/Genetic_engineering" title="Genetic engineering">genetic engineering</a>. By constructing a <a href="/wiki/Plasmid" title="Plasmid">plasmid</a> which contains an antibiotic resistance gene as well as the gene being engineered or expressed, a researcher can ensure that when bacteria replicate, only the copies which carry along the plasmid survive. This ensures that the gene being manipulated passes along when the bacteria replicates.</p>
<p>The most commonly used antibiotics in genetic engineering are generally "older" antibiotics which have largely fallen out of use in clinical practice. These include:</p>
<ul>
<li><a href="/wiki/Ampicillin" title="Ampicillin">ampicillin</a></li>
<li><a href="/wiki/Kanamycin" title="Kanamycin">kanamycin</a></li>
<li><a href="/wiki/Tetracycline" title="Tetracycline">tetracycline</a></li>
<li><a href="/wiki/Chloramphenicol" title="Chloramphenicol">chloramphenicol</a></li>
</ul>
<p>Industrially the use of antibiotic resistance is disfavored since maintaining bacterial cultures would require feeding them large quantities of antibiotics. Instead, the use of <a href="/wiki/Auxotrophic" title="Auxotrophic" class="mw-redirect">auxotrophic</a> bacterial strains (and function-replacement plasmids) is preferred.</p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Antibiotic_resistance&amp;action=edit&amp;section=15" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="/wiki/Drug_resistance" title="Drug resistance">Drug resistance</a></li>
<li><a href="/wiki/Multidrug_resistance" title="Multidrug resistance" class="mw-redirect">Multidrug resistance</a></li>
<li><a href="/wiki/Antibacterial_soap" title="Antibacterial soap">Antibacterial soap</a></li>
<li><a href="/wiki/Bacterial_conjugation" title="Bacterial conjugation">Bacterial conjugation</a></li>
<li><a href="/wiki/Drug_of_last_resort" title="Drug of last resort">Drug of last resort</a></li>
<li><a href="/wiki/Efflux" title="Efflux" class="mw-redirect">Efflux</a></li>
<li><a href="/wiki/Nosocomial_infection" title="Nosocomial infection">Nosocomial infection</a></li>
<li><a href="/wiki/Pesticide_resistance" title="Pesticide resistance">Pesticide resistance</a></li>
<li><a href="/wiki/Repressor_lexA" title="Repressor lexA">LexA</a></li>
<li><a href="/wiki/Tuberculosis" title="Tuberculosis">Tuberculosis</a></li>
<li><a href="/wiki/List_of_environment_topics" title="List of environment topics" class="mw-redirect">List of environment topics</a></li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Antibiotic_resistance&amp;action=edit&amp;section=16" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<ul>
<li><cite style="font-style:normal" class="" id="CITEREFSoulsby_EJ2005">Soulsby EJ (2005). "<a href="http://www.bmj.com/cgi/content/full/331/7527/1219" class="external text" title="http://www.bmj.com/cgi/content/full/331/7527/1219" rel="nofollow">Resistance to antimicrobials in humans and animals</a>". <i>BMJ</i> <b>331</b> (7527): 1219–20. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fbmj.331.7527.1219" class="external text" title="http://dx.doi.org/10.1136%2Fbmj.331.7527.1219" rel="nofollow">10.1136/bmj.331.7527.1219</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16308360" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16308360">PMID 16308360</a><span class="printonly">. <a href="http://www.bmj.com/cgi/content/full/331/7527/1219" class="external free" title="http://www.bmj.com/cgi/content/full/331/7527/1219" rel="nofollow">http://www.bmj.com/cgi/content/full/331/7527/1219</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Resistance+to+antimicrobials+in+humans+and+animals&amp;rft.jtitle=BMJ&amp;rft.aulast=Soulsby+EJ&amp;rft.au=Soulsby+EJ&amp;rft.date=2005&amp;rft.volume=331&amp;rft.issue=7527&amp;rft.pages=1219%E2%80%9320&amp;rft_id=info:doi/10.1136%2Fbmj.331.7527.1219&amp;rft_id=info:pmid/16308360&amp;rft_id=http%3A%2F%2Fwww.bmj.com%2Fcgi%2Fcontent%2Ffull%2F331%2F7527%2F1219&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li><cite style="font-style:normal" class="" id="CITEREFAriasMurray.2C_Barbara_E.2009">Arias, Cesar A.; Murray, Barbara E. (2009). "Antibiotic-Resistant Bugs in the 21st Century — A Clinical Super-Challenge". <i><a href="/wiki/New_England_Journal_of_Medicine" title="New England Journal of Medicine">New England Journal of Medicine</a></i> <b>360</b> (5): 439–443. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMp0804651" class="external text" title="http://dx.doi.org/10.1056%2FNEJMp0804651" rel="nofollow">10.1056/NEJMp0804651</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Antibiotic-Resistant+Bugs+in+the+21st+Century+%E2%80%94+A+Clinical+Super-Challenge&amp;rft.jtitle=%5B%5BNew+England+Journal+of+Medicine%5D%5D&amp;rft.aulast=Arias&amp;rft.aufirst=Cesar+A.&amp;rft.au=Arias%2C+Cesar+A.&amp;rft.au=Murray%2C+Barbara+E.&amp;rft.date=2009&amp;rft.volume=360&amp;rft.issue=5&amp;rft.pages=439%E2%80%93443&amp;rft_id=info:doi/10.1056%2FNEJMp0804651&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
</ul>
<p><a name="Footnotes" id="Footnotes"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Antibiotic_resistance&amp;action=edit&amp;section=17" title="Edit section: Footnotes">edit</a>]</span> <span class="mw-headline">Footnotes</span></h2>
<div class="references-small references-column-count references-column-count-2" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="cite_note-0"><b><a href="#cite_ref-0" title="">^</a></b> Ochiai, K., Yamanaka, T Kimura K and Sawada, O (1959) Inheritance of drug resistance (and its tranfer) between Shigella strains and Between Shigella and E.coli strains. Hihon Iji Shimpor 1861: 34 (in Japanese)</li>
<li id="cite_note-pmid15869329-1"><b><a href="#cite_ref-pmid15869329_1-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCirz_RT.2C_Chin_JK.2C_Andes_DR.2C_de_Cr.C3.A9cy-Lagard_V.2C_Craig_WA.2C_Romesberg_FE2005">Cirz RT, Chin JK, Andes DR, de Crécy-Lagard V, Craig WA, Romesberg FE (2005). "<a href="http://biology.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pbio.0030176" class="external text" title="http://biology.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pbio.0030176" rel="nofollow">Inhibition of mutation and combating the evolution of antibiotic resistance</a>". <i>PLoS Biol.</i> <b>3</b> (6): e176. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1371%2Fjournal.pbio.0030176" class="external text" title="http://dx.doi.org/10.1371%2Fjournal.pbio.0030176" rel="nofollow">10.1371/journal.pbio.0030176</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15869329" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15869329">PMID 15869329</a><span class="printonly">. <a href="http://biology.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pbio.0030176" class="external free" title="http://biology.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pbio.0030176" rel="nofollow">http://biology.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pbio.0030176</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Inhibition+of+mutation+and+combating+the+evolution+of+antibiotic+resistance&amp;rft.jtitle=PLoS+Biol.&amp;rft.aulast=Cirz+RT%2C+Chin+JK%2C+Andes+DR%2C+de+Cr%C3%A9cy-Lagard+V%2C+Craig+WA%2C+Romesberg+FE&amp;rft.au=Cirz+RT%2C+Chin+JK%2C+Andes+DR%2C+de+Cr%C3%A9cy-Lagard+V%2C+Craig+WA%2C+Romesberg+FE&amp;rft.date=2005&amp;rft.volume=3&amp;rft.issue=6&amp;rft.pages=e176&amp;rft_id=info:doi/10.1371%2Fjournal.pbio.0030176&amp;rft_id=info:pmid/15869329&amp;rft_id=http%3A%2F%2Fbiology.plosjournals.org%2Fperlserv%2F%3Frequest%3Dget-document%26doi%3D10.1371%2Fjournal.pbio.0030176&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Ponte-SucreA-2">^ <a href="#cite_ref-Ponte-SucreA_2-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ponte-SucreA_2-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="book" id="CITEREFPonte-Sucre.2C_A_.28editor.292009">Ponte-Sucre, A (editor) (2009). <i>ABC Transporters in Microorganisms</i>. Caister Academic Press. <a href="/wiki/Special:BookSources/9781904455493" class="internal">ISBN 978-1-904455-49-3</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=ABC+Transporters+in+Microorganisms&amp;rft.aulast=Ponte-Sucre%2C+A+%28editor%29&amp;rft.au=Ponte-Sucre%2C+A+%28editor%29&amp;rft.date=2009&amp;rft.pub=Caister+Academic+Press&amp;rft.isbn=978-1-904455-49-3&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17146447-3"><b><a href="#cite_ref-pmid17146447_3-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBoyle-Vavra_S.2C_Daum_RS2007">Boyle-Vavra S, Daum RS (2007). "Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin". <i>Lab. Invest.</i> <b>87</b> (1): 3–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1038%2Flabinvest.3700501" class="external text" title="http://dx.doi.org/10.1038%2Flabinvest.3700501" rel="nofollow">10.1038/labinvest.3700501</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17146447" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17146447">PMID 17146447</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Community-acquired+methicillin-resistant+Staphylococcus+aureus%3A+the+role+of+Panton-Valentine+leukocidin&amp;rft.jtitle=Lab.+Invest.&amp;rft.aulast=Boyle-Vavra+S%2C+Daum+RS&amp;rft.au=Boyle-Vavra+S%2C+Daum+RS&amp;rft.date=2007&amp;rft.volume=87&amp;rft.issue=1&amp;rft.pages=3%E2%80%939&amp;rft_id=info:doi/10.1038%2Flabinvest.3700501&amp;rft_id=info:pmid/17146447&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17479885-4"><b><a href="#cite_ref-pmid17479885_4-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMaree_CL.2C_Daum_RS.2C_Boyle-Vavra_S.2C_Matayoshi_K.2C_Miller_LG2007">Maree CL, Daum RS, Boyle-Vavra S, Matayoshi K, Miller LG (2007). "<a href="http://www.cdc.gov/eid/content/13/2/236.htm?s_cid=eid236_e" class="external text" title="http://www.cdc.gov/eid/content/13/2/236.htm?s_cid=eid236_e" rel="nofollow">Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections</a>". <i>Emerging Infect. Dis.</i> <b>13</b> (2): 236–42. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17479885" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17479885">PMID 17479885</a><span class="printonly">. <a href="http://www.cdc.gov/eid/content/13/2/236.htm?s_cid=eid236_e" class="external free" title="http://www.cdc.gov/eid/content/13/2/236.htm?s_cid=eid236_e" rel="nofollow">http://www.cdc.gov/eid/content/13/2/236.htm?s_cid=eid236_e</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Community-associated+methicillin-resistant+Staphylococcus+aureus+isolates+causing+healthcare-associated+infections&amp;rft.jtitle=Emerging+Infect.+Dis.&amp;rft.aulast=Maree+CL%2C+Daum+RS%2C+Boyle-Vavra+S%2C+Matayoshi+K%2C+Miller+LG&amp;rft.au=Maree+CL%2C+Daum+RS%2C+Boyle-Vavra+S%2C+Matayoshi+K%2C+Miller+LG&amp;rft.date=2007&amp;rft.volume=13&amp;rft.issue=2&amp;rft.pages=236%E2%80%9342&amp;rft_id=info:pmid/17479885&amp;rft_id=http%3A%2F%2Fwww.cdc.gov%2Feid%2Fcontent%2F13%2F2%2F236.htm%3Fs_cid%3Deid236_e&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-5"><b><a href="#cite_ref-5" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFDivision_of_Bacterial_and_Mycotic_Diseases2005">Division of Bacterial and Mycotic Diseases (2005-10-11). <a href="http://www.cdc.gov/ncidod/dbmd/diseaseinfo/groupastreptococcal_g.htm" class="external text" title="http://www.cdc.gov/ncidod/dbmd/diseaseinfo/groupastreptococcal_g.htm" rel="nofollow">"Group A Streptococcal (GAS) Disease (strep throat, necrotizing fasciitis, impetigo) -- Frequently Asked Questions"</a>. Centers for Disease Control and Prevention<span class="printonly">. <a href="http://www.cdc.gov/ncidod/dbmd/diseaseinfo/groupastreptococcal_g.htm" class="external free" title="http://www.cdc.gov/ncidod/dbmd/diseaseinfo/groupastreptococcal_g.htm" rel="nofollow">http://www.cdc.gov/ncidod/dbmd/diseaseinfo/groupastreptococcal_g.htm</a></span><span class="reference-accessdate">. Retrieved on 2007-12-11</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Group+A+Streptococcal+%28GAS%29+Disease+%28strep+throat%2C+necrotizing+fasciitis%2C+impetigo%29+--+Frequently+Asked+Questions&amp;rft.atitle=&amp;rft.aulast=Division+of+Bacterial+and+Mycotic+Diseases&amp;rft.au=Division+of+Bacterial+and+Mycotic+Diseases&amp;rft.date=2005-10-11&amp;rft.pub=Centers+for+Disease+Control+and+Prevention&amp;rft_id=http%3A%2F%2Fwww.cdc.gov%2Fncidod%2Fdbmd%2Fdiseaseinfo%2Fgroupastreptococcal_g.htm&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15109426-6">^ <a href="#cite_ref-pmid15109426_6-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15109426_6-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFAlbrich_WC.2C_Monnet_DL.2C_Harbarth_S2004">Albrich WC, Monnet DL, Harbarth S (2004). "<a href="http://www.cdc.gov/ncidod/eid/vol10no3/03-0252.htm" class="external text" title="http://www.cdc.gov/ncidod/eid/vol10no3/03-0252.htm" rel="nofollow">Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes</a>". <i>Emerging Infect. Dis.</i> <b>10</b> (3): 514–7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15109426" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15109426">PMID 15109426</a><span class="printonly">. <a href="http://www.cdc.gov/ncidod/eid/vol10no3/03-0252.htm" class="external free" title="http://www.cdc.gov/ncidod/eid/vol10no3/03-0252.htm" rel="nofollow">http://www.cdc.gov/ncidod/eid/vol10no3/03-0252.htm</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Antibiotic+selection+pressure+and+resistance+in+Streptococcus+pneumoniae+and+Streptococcus+pyogenes&amp;rft.jtitle=Emerging+Infect.+Dis.&amp;rft.aulast=Albrich+WC%2C+Monnet+DL%2C+Harbarth+S&amp;rft.au=Albrich+WC%2C+Monnet+DL%2C+Harbarth+S&amp;rft.date=2004&amp;rft.volume=10&amp;rft.issue=3&amp;rft.pages=514%E2%80%937&amp;rft_id=info:pmid/15109426&amp;rft_id=http%3A%2F%2Fwww.cdc.gov%2Fncidod%2Feid%2Fvol10no3%2F03-0252.htm&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Cornelis-7"><b><a href="#cite_ref-Cornelis_7-0" title="">^</a></b> <cite style="font-style:normal" class="book" id="CITEREFCornelis_P_.28editor.29.2008">Cornelis P (editor). (2008). <i><a href="http://www.horizonpress.com/pseudo" class="external text" title="http://www.horizonpress.com/pseudo" rel="nofollow">Pseudomonas: Genomics and Molecular Biology</a></i> (1st ed.). Caister Academic Press. <a href="/wiki/Special:BookSources/9781904455196" class="internal">ISBN 978-1-904455-19-6</a> ]<span class="printonly">. <a href="http://www.horizonpress.com/pseudo" class="external free" title="http://www.horizonpress.com/pseudo" rel="nofollow">http://www.horizonpress.com/pseudo</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Pseudomonas%3A+Genomics+and+Molecular+Biology&amp;rft.aulast=Cornelis+P+%28editor%29.&amp;rft.au=Cornelis+P+%28editor%29.&amp;rft.date=2008&amp;rft.edition=1st&amp;rft.pub=Caister+Academic+Press&amp;rft.isbn=978-1-904455-19-6+%5D&amp;rft_id=http%3A%2F%2Fwww.horizonpress.com%2Fpseudo&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-8"><b><a href="#cite_ref-8" title="">^</a></b> Gerding D.N., Johnson S., Peterson L.R., Mulligan M.E. and Silva J. Jr. (1995). <i>Clostridium difficile</i>-associated diarrhea and colitis. Infect. Control. Hosp. Epidemiol. 16:459-477.</li>
<li id="cite_note-McDonald_2005-9"><b><a href="#cite_ref-McDonald_2005_9-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMcDonald_L2005">McDonald L (2005). "<a href="http://www.cdc.gov/ncidod/dhqp/pdf/infDis/Cdiff_ICHE08_05.pdf" class="external text" title="http://www.cdc.gov/ncidod/dhqp/pdf/infDis/Cdiff_ICHE08_05.pdf" rel="nofollow"><i>Clostridium difficile</i>: responding to a new threat from an old enemy</a>" (PDF). <i>Infect. Control. Hosp. Epidemiol.</i> <b>26</b> (8): 672–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1086%2F502600" class="external text" title="http://dx.doi.org/10.1086%2F502600" rel="nofollow">10.1086/502600</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16156321" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16156321">PMID 16156321</a><span class="printonly">. <a href="http://www.cdc.gov/ncidod/dhqp/pdf/infDis/Cdiff_ICHE08_05.pdf" class="external free" title="http://www.cdc.gov/ncidod/dhqp/pdf/infDis/Cdiff_ICHE08_05.pdf" rel="nofollow">http://www.cdc.gov/ncidod/dhqp/pdf/infDis/Cdiff_ICHE08_05.pdf</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=%27%27Clostridium+difficile%27%27%3A+responding+to+a+new+threat+from+an+old+enemy&amp;rft.jtitle=Infect.+Control.+Hosp.+Epidemiol.&amp;rft.aulast=McDonald+L&amp;rft.au=McDonald+L&amp;rft.date=2005&amp;rft.volume=26&amp;rft.issue=8&amp;rft.pages=672%E2%80%935&amp;rft_id=info:doi/10.1086%2F502600&amp;rft_id=info:pmid/16156321&amp;rft_id=http%3A%2F%2Fwww.cdc.gov%2Fncidod%2Fdhqp%2Fpdf%2FinfDis%2FCdiff_ICHE08_05.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Johnson1999-10"><b><a href="#cite_ref-Johnson1999_10-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFJohnson_S..2C_Samore_M.H..2C_Farrow_K.A..2C_.27.27et_al..27.271999">Johnson S., Samore M.H., Farrow K.A., <i>et al.</i> (1999). "<a href="http://content.nejm.org/cgi/content/full/341/22/1645" class="external text" title="http://content.nejm.org/cgi/content/full/341/22/1645" rel="nofollow">Epidemics of diarrhea caused by a clindamycin-resistant strain of <i>Clostridium difficile</i> in four hospitals</a>". <i>New England Journal of Medicine</i> <b>341</b>: 1645–1651. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJM199911253412203" class="external text" title="http://dx.doi.org/10.1056%2FNEJM199911253412203" rel="nofollow">10.1056/NEJM199911253412203</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16322602" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16322602">PMID 16322602</a><span class="printonly">. <a href="http://content.nejm.org/cgi/content/full/341/22/1645" class="external free" title="http://content.nejm.org/cgi/content/full/341/22/1645" rel="nofollow">http://content.nejm.org/cgi/content/full/341/22/1645</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Epidemics+of+diarrhea+caused+by+a+clindamycin-resistant+strain+of+%27%27Clostridium+difficile%27%27+in+four+hospitals&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.aulast=Johnson+S.%2C+Samore+M.H.%2C+Farrow+K.A.%2C+%27%27et+al.%27%27&amp;rft.au=Johnson+S.%2C+Samore+M.H.%2C+Farrow+K.A.%2C+%27%27et+al.%27%27&amp;rft.date=1999&amp;rft.volume=341&amp;rft.pages=1645%E2%80%931651&amp;rft_id=info:doi/10.1056%2FNEJM199911253412203&amp;rft_id=info:pmid/16322602&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fcontent%2Ffull%2F341%2F22%2F1645&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Loo_2005-11"><b><a href="#cite_ref-Loo_2005_11-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLoo_V.2C_Poirier_L.2C_Miller_M.2C_.27.27et_al.27.272005">Loo V, Poirier L, Miller M, <i>et al</i> (2005). "A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality". <i>N Engl J Med</i> <b>353</b> (23): 2442–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa051639" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa051639" rel="nofollow">10.1056/NEJMoa051639</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16322602" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16322602">PMID 16322602</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+predominantly+clonal+multi-institutional+outbreak+of+Clostridium+difficile-associated+diarrhea+with+high+morbidity+and+mortality&amp;rft.jtitle=N+Engl+J+Med&amp;rft.aulast=Loo+V%2C+Poirier+L%2C+Miller+M%2C+%27%27et+al%27%27&amp;rft.au=Loo+V%2C+Poirier+L%2C+Miller+M%2C+%27%27et+al%27%27&amp;rft.date=2005&amp;rft.volume=353&amp;rft.issue=23&amp;rft.pages=2442%E2%80%939&amp;rft_id=info:doi/10.1056%2FNEJMoa051639&amp;rft_id=info:pmid/16322602&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15549020-12"><b><a href="#cite_ref-pmid15549020_12-0" title="">^</a></b> <cite style="font-style:normal" class="">"<a href="http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5345a1.htm" class="external text" title="http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5345a1.htm" rel="nofollow">Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004</a>". <i>MMWR Morb. Mortal. Wkly. Rep.</i> <b>53</b> (45): 1063–6. 2004. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15549020" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15549020">PMID 15549020</a><span class="printonly">. <a href="http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5345a1.htm" class="external free" title="http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5345a1.htm" rel="nofollow">http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5345a1.htm</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Acinetobacter+baumannii+infections+among+patients+at+military+medical+facilities+treating+injured+U.S.+service+members%2C+2002-2004&amp;rft.jtitle=MMWR+Morb.+Mortal.+Wkly.+Rep.&amp;rft.date=2004&amp;rft.volume=53&amp;rft.issue=45&amp;rft.pages=1063%E2%80%936&amp;rft_id=info:pmid/15549020&amp;rft_id=http%3A%2F%2Fwww.cdc.gov%2Fmmwr%2Fpreview%2Fmmwrhtml%2Fmm5345a1.htm&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-13"><b><a href="#cite_ref-13" title="">^</a></b> <a href="http://www.medscape.com/viewarticle/575837" class="external text" title="http://www.medscape.com/viewarticle/575837" rel="nofollow">Medscape abstract on Acinetobacter baumannii: Acinetobacter baumannii: An Emerging Multidrug-resistant Threat.</a></li>
<li id="cite_note-14"><b><a href="#cite_ref-14" title="">^</a></b> <cite style="font-style:normal" class="">"<a href="http://www.economist.com/displaystory.cfm?story_id=10205187&amp;fsrc=RSS" class="external text" title="http://www.economist.com/displaystory.cfm?story_id=10205187&amp;fsrc=RSS" rel="nofollow">Drug Resistant Infections: Riding Piggyback</a>". <i>The Economist</i>. November 29, 2007<span class="printonly">. <a href="http://www.economist.com/displaystory.cfm?story_id=10205187&amp;fsrc=RSS" class="external free" title="http://www.economist.com/displaystory.cfm?story_id=10205187&amp;fsrc=RSS" rel="nofollow">http://www.economist.com/displaystory.cfm?story_id=10205187&amp;fsrc=RSS</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Drug+Resistant+Infections%3A+Riding+Piggyback&amp;rft.jtitle=The+Economist&amp;rft.date=November+29%2C+2007&amp;rft_id=http%3A%2F%2Fwww.economist.com%2Fdisplaystory.cfm%3Fstory_id%3D10205187%26amp%3Bfsrc%3DRSS&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-15"><b><a href="#cite_ref-15" title="">^</a></b> <a href="http://www.parliament.the-stationery-office.co.uk/pa/ld199798/ldselect/ldsctech/081vii/st0706.htm" class="external text" title="http://www.parliament.the-stationery-office.co.uk/pa/ld199798/ldselect/ldsctech/081vii/st0706.htm" rel="nofollow">UK Swann report</a></li>
<li id="cite_note-16"><b><a href="#cite_ref-16" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCastanon_J.I.2007">Castanon J.I. (2007). "History of the use of antibiotic as growth promoters in European poultry feeds". <i>Poult. Sci.</i> <b>86</b> (11): 2466–71. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.3382%2Fps.2007-00249" class="external text" title="http://dx.doi.org/10.3382%2Fps.2007-00249" rel="nofollow">10.3382/ps.2007-00249</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17954599" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17954599">PMID 17954599</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=History+of+the+use+of+antibiotic+as+growth+promoters+in+European+poultry+feeds&amp;rft.jtitle=Poult.+Sci.&amp;rft.aulast=Castanon+J.I.&amp;rft.au=Castanon+J.I.&amp;rft.date=2007&amp;rft.volume=86&amp;rft.issue=11&amp;rft.pages=2466%E2%80%9371&amp;rft_id=info:doi/10.3382%2Fps.2007-00249&amp;rft_id=info:pmid/17954599&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-17"><b><a href="#cite_ref-17" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBengtsson_B..2C_Wierup_M.2006">Bengtsson B., Wierup M. (2006). "Antimicrobial resistance in Scandinavia after ban of antimicrobial growth promoters". <i>Anim. Biotechnol.</i> <b>17</b> (2): 147–56. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1080%2F10495390600956920" class="external text" title="http://dx.doi.org/10.1080%2F10495390600956920" rel="nofollow">10.1080/10495390600956920</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17127526" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17127526">PMID 17127526</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Antimicrobial+resistance+in+Scandinavia+after+ban+of+antimicrobial+growth+promoters&amp;rft.jtitle=Anim.+Biotechnol.&amp;rft.aulast=Bengtsson+B.%2C+Wierup+M.&amp;rft.au=Bengtsson+B.%2C+Wierup+M.&amp;rft.date=2006&amp;rft.volume=17&amp;rft.issue=2&amp;rft.pages=147%E2%80%9356&amp;rft_id=info:doi/10.1080%2F10495390600956920&amp;rft_id=info:pmid/17127526&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-18"><b><a href="#cite_ref-18" title="">^</a></b> <a href="http://www.fda.gov/cvm/HRESP106_157.htm" class="external text" title="http://www.fda.gov/cvm/HRESP106_157.htm" rel="nofollow">1977 FDA report</a></li>
<li id="cite_note-19"><b><a href="#cite_ref-19" title="">^</a></b> <a href="http://www.nap.edu/catalog.php?record_id=21" class="external text" title="http://www.nap.edu/catalog.php?record_id=21" rel="nofollow">NAP.edu 1980 study</a></li>
<li id="cite_note-20"><b><a href="#cite_ref-20" title="">^</a></b> <a href="http://www.gao.gov/new.items/d04490.pdf" class="external text" title="http://www.gao.gov/new.items/d04490.pdf" rel="nofollow">2004 GAO study</a></li>
<li id="cite_note-21"><b><a href="#cite_ref-21" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSapkota_AR.2C_Lefferts_LY.2C_McKenzie_S.2C_Walker_P2007">Sapkota AR, Lefferts LY, McKenzie S, Walker P (May 2007). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1867957" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1867957" rel="nofollow">What do we feed to food-production animals? A review of animal feed ingredients and their potential impacts on human health</a>". <i>Environ. Health Perspect.</i> <b>115</b> (5): 663–70. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1289%2Fehp.9760" class="external text" title="http://dx.doi.org/10.1289%2Fehp.9760" rel="nofollow">10.1289/ehp.9760</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17520050" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17520050">PMID 17520050</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=What+do+we+feed+to+food-production+animals%3F+A+review+of+animal+feed+ingredients+and+their+potential+impacts+on+human+health&amp;rft.jtitle=Environ.+Health+Perspect.&amp;rft.aulast=Sapkota+AR%2C+Lefferts+LY%2C+McKenzie+S%2C+Walker+P&amp;rft.au=Sapkota+AR%2C+Lefferts+LY%2C+McKenzie+S%2C+Walker+P&amp;rft.date=May+2007&amp;rft.volume=115&amp;rft.issue=5&amp;rft.pages=663%E2%80%9370&amp;rft_id=info:doi/10.1289%2Fehp.9760&amp;rft_id=info:pmid/17520050&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-22"><b><a href="#cite_ref-22" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMathew_AG.2C_Cissell_R.2C_Liamthong_S2007">Mathew AG, Cissell R, Liamthong S (2007). "Antibiotic resistance in bacteria associated with food animals: a United States perspective of livestock production". <i>Foodborne Pathog. Dis.</i> <b>4</b> (2): 115–33. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1089%2Ffpd.2006.0066" class="external text" title="http://dx.doi.org/10.1089%2Ffpd.2006.0066" rel="nofollow">10.1089/fpd.2006.0066</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17600481" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17600481">PMID 17600481</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Antibiotic+resistance+in+bacteria+associated+with+food+animals%3A+a+United+States+perspective+of+livestock+production&amp;rft.jtitle=Foodborne+Pathog.+Dis.&amp;rft.aulast=Mathew+AG%2C+Cissell+R%2C+Liamthong+S&amp;rft.au=Mathew+AG%2C+Cissell+R%2C+Liamthong+S&amp;rft.date=2007&amp;rft.volume=4&amp;rft.issue=2&amp;rft.pages=115%E2%80%9333&amp;rft_id=info:doi/10.1089%2Ffpd.2006.0066&amp;rft_id=info:pmid/17600481&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-23"><b><a href="#cite_ref-23" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBaker_R2006">Baker R (2006). "Health management with reduced antibiotic use - the U.S. experience". <i>Anim. Biotechnol.</i> <b>17</b> (2): 195–205. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1080%2F10495390600962274" class="external text" title="http://dx.doi.org/10.1080%2F10495390600962274" rel="nofollow">10.1080/10495390600962274</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17127530" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17127530">PMID 17127530</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Health+management+with+reduced+antibiotic+use+-+the+U.S.+experience&amp;rft.jtitle=Anim.+Biotechnol.&amp;rft.aulast=Baker+R&amp;rft.au=Baker+R&amp;rft.date=2006&amp;rft.volume=17&amp;rft.issue=2&amp;rft.pages=195%E2%80%93205&amp;rft_id=info:doi/10.1080%2F10495390600962274&amp;rft_id=info:pmid/17127530&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-24"><b><a href="#cite_ref-24" title="">^</a></b> <a href="http://www.ucsusa.org/food_and_environment/antibiotics_and_food/hogging-it-estimates-of-antimicrobial-abuse-in-livestock.html" class="external text" title="http://www.ucsusa.org/food_and_environment/antibiotics_and_food/hogging-it-estimates-of-antimicrobial-abuse-in-livestock.html" rel="nofollow">Executive summary from the UCS report "Hogging It: Estimates of Antimicrobial Abuse in Livestock", January 2001</a></li>
<li id="cite_note-25"><b><a href="#cite_ref-25" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFNelson_JM.2C_Chiller_TM.2C_Powers_JH.2C_Angulo_FJ2007">Nelson JM, Chiller TM, Powers JH, Angulo FJ (2007). "<a href="http://www.journals.uchicago.edu/CID/journal/issues/v44n7/41120/41120.html" class="external text" title="http://www.journals.uchicago.edu/CID/journal/issues/v44n7/41120/41120.html" rel="nofollow">Fluoroquinolone-resistant <i>Campylobacter</i> species and the withdrawal of fluoroquinolones from use in poultry: A public health success story</a>" (<sup class="noprint Inline-Template"><span title="&#160;since June 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Dead_external_links" title="Wikipedia:Dead external links">dead link</a></i>]</span></sup> – <sup><a href="http://scholar.google.co.uk/scholar?hl=en&amp;lr=&amp;q=intitle%3AFluoroquinolone-resistant+%27%27Campylobacter%27%27+species+and+the+withdrawal+of+fluoroquinolones+from+use+in+poultry%3A+A+public+health+success+story&amp;as_publication=Clin+Infect+Dis&amp;as_ylo=2007&amp;as_yhi=2007&amp;btnG=Search" class="external text" title="http://scholar.google.co.uk/scholar?hl=en&amp;lr=&amp;q=intitle%3AFluoroquinolone-resistant+%27%27Campylobacter%27%27+species+and+the+withdrawal+of+fluoroquinolones+from+use+in+poultry%3A+A+public+health+success+story&amp;as_publication=Clin+Infect+Dis&amp;as_ylo=2007&amp;as_yhi=2007&amp;btnG=Search" rel="nofollow">Scholar search</a></sup>). <i>Clin Infect Dis</i> <b>44</b>: 977–80. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1086%2F512369" class="external text" title="http://dx.doi.org/10.1086%2F512369" rel="nofollow">10.1086/512369</a></span><span class="printonly">. <a href="http://www.journals.uchicago.edu/CID/journal/issues/v44n7/41120/41120.html" class="external free" title="http://www.journals.uchicago.edu/CID/journal/issues/v44n7/41120/41120.html" rel="nofollow">http://www.journals.uchicago.edu/CID/journal/issues/v44n7/41120/41120.html</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Fluoroquinolone-resistant+%27%27Campylobacter%27%27+species+and+the+withdrawal+of+fluoroquinolones+from+use+in+poultry%3A+A+public+health+success+story&amp;rft.jtitle=Clin+Infect+Dis&amp;rft.aulast=Nelson+JM%2C+Chiller+TM%2C+Powers+JH%2C+Angulo+FJ&amp;rft.au=Nelson+JM%2C+Chiller+TM%2C+Powers+JH%2C+Angulo+FJ&amp;rft.date=2007&amp;rft.volume=44&amp;rft.pages=977%26ndash%3B80&amp;rft_id=info:doi/10.1086%2F512369&amp;rft_id=http%3A%2F%2Fwww.journals.uchicago.edu%2FCID%2Fjournal%2Fissues%2Fv44n7%2F41120%2F41120.html&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-26"><b><a href="#cite_ref-26" title="">^</a></b> <a href="http://www.govtrack.us/congress/bill.xpd?bill=s110-549" class="external text" title="http://www.govtrack.us/congress/bill.xpd?bill=s110-549" rel="nofollow">US Senate Bill S. 549: Preservation of Antibiotics for Medical Treatment Act of 2007</a></li>
<li id="cite_note-27"><b><a href="#cite_ref-27" title="">^</a></b> <a href="http://www.govtrack.us/congress/bill.xpd?bill=h110-962" class="external text" title="http://www.govtrack.us/congress/bill.xpd?bill=h110-962" rel="nofollow">US House Bill H.R. 962: Preservation of Antibiotics for Medical Treatment Act of 2007</a></li>
<li id="cite_note-pmid12781017-28"><b><a href="#cite_ref-pmid12781017_28-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMcCusker_ME.2C_Harris_AD.2C_Perencevich_E.2C_Roghmann_MC2003">McCusker ME, Harris AD, Perencevich E, Roghmann MC (2003). "<a href="http://www.cdc.gov/ncidod/eid/vol9no6/02-0385.htm" class="external text" title="http://www.cdc.gov/ncidod/eid/vol9no6/02-0385.htm" rel="nofollow">Fluoroquinolone use and Clostridium difficile-associated diarrhea</a>". <i>Emerging Infect. Dis.</i> <b>9</b> (6): 730–3. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12781017" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12781017">PMID 12781017</a><span class="printonly">. <a href="http://www.cdc.gov/ncidod/eid/vol9no6/02-0385.htm" class="external free" title="http://www.cdc.gov/ncidod/eid/vol9no6/02-0385.htm" rel="nofollow">http://www.cdc.gov/ncidod/eid/vol9no6/02-0385.htm</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Fluoroquinolone+use+and+Clostridium+difficile-associated+diarrhea&amp;rft.jtitle=Emerging+Infect.+Dis.&amp;rft.aulast=McCusker+ME%2C+Harris+AD%2C+Perencevich+E%2C+Roghmann+MC&amp;rft.au=McCusker+ME%2C+Harris+AD%2C+Perencevich+E%2C+Roghmann+MC&amp;rft.date=2003&amp;rft.volume=9&amp;rft.issue=6&amp;rft.pages=730%E2%80%933&amp;rft_id=info:pmid/12781017&amp;rft_id=http%3A%2F%2Fwww.cdc.gov%2Fncidod%2Feid%2Fvol9no6%2F02-0385.htm&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9866738-29"><b><a href="#cite_ref-pmid9866738_29-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFrost_F.2C_Craun_GF.2C_Calderon_RL1998">Frost F, Craun GF, Calderon RL (1998). "<a href="http://www.cdc.gov/ncidod/eid/vol4no4/frost.htm" class="external text" title="http://www.cdc.gov/ncidod/eid/vol4no4/frost.htm" rel="nofollow">Increasing hospitalization and death possibly due to Clostridium difficile diarrheal disease</a>". <i>Emerging Infect. Dis.</i> <b>4</b> (4): 619–25. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9866738" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9866738">PMID 9866738</a><span class="printonly">. <a href="http://www.cdc.gov/ncidod/eid/vol4no4/frost.htm" class="external free" title="http://www.cdc.gov/ncidod/eid/vol4no4/frost.htm" rel="nofollow">http://www.cdc.gov/ncidod/eid/vol4no4/frost.htm</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Increasing+hospitalization+and+death+possibly+due+to+Clostridium+difficile+diarrheal+disease&amp;rft.jtitle=Emerging+Infect.+Dis.&amp;rft.aulast=Frost+F%2C+Craun+GF%2C+Calderon+RL&amp;rft.au=Frost+F%2C+Craun+GF%2C+Calderon+RL&amp;rft.date=1998&amp;rft.volume=4&amp;rft.issue=4&amp;rft.pages=619%E2%80%9325&amp;rft_id=info:pmid/9866738&amp;rft_id=http%3A%2F%2Fwww.cdc.gov%2Fncidod%2Feid%2Fvol4no4%2Ffrost.htm&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-30"><b><a href="#cite_ref-30" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFN_Chanishvili.2C_T_Chanishvili.2C_M._Tediashvili.2C_P.A._Barrow2001">N Chanishvili, T Chanishvili, M. Tediashvili, P.A. Barrow (2001). "<a href="http://cat.inist.fr/?aModele=afficheN&amp;cpsidt=1096871" class="external text" title="http://cat.inist.fr/?aModele=afficheN&amp;cpsidt=1096871" rel="nofollow">Phages and their application against drug-resistant bacteria</a>". <i>J. Chem. Technol. Biotechnol.)</i> <b>76</b>: 689–699. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fjctb.438" class="external text" title="http://dx.doi.org/10.1002%2Fjctb.438" rel="nofollow">10.1002/jctb.438</a></span><span class="printonly">. <a href="http://cat.inist.fr/?aModele=afficheN&amp;cpsidt=1096871" class="external free" title="http://cat.inist.fr/?aModele=afficheN&amp;cpsidt=1096871" rel="nofollow">http://cat.inist.fr/?aModele=afficheN&amp;cpsidt=1096871</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Phages+and+their+application+against+drug-resistant+bacteria&amp;rft.jtitle=J.+Chem.+Technol.+Biotechnol.%29&amp;rft.aulast=N+Chanishvili%2C+T+Chanishvili%2C+M.+Tediashvili%2C+P.A.+Barrow&amp;rft.au=N+Chanishvili%2C+T+Chanishvili%2C+M.+Tediashvili%2C+P.A.+Barrow&amp;rft.date=2001&amp;rft.volume=76&amp;rft.pages=689%E2%80%93699&amp;rft_id=info:doi/10.1002%2Fjctb.438&amp;rft_id=http%3A%2F%2Fcat.inist.fr%2F%3FaModele%3DafficheN%26cpsidt%3D1096871&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-31"><b><a href="#cite_ref-31" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFD._Jikia.2C_N._Chkhaidze.2C_E._Imedashvili.2C_I._Mgaloblishvili.2C_G._Tsitlanadze2005">D. Jikia, N. Chkhaidze, E. Imedashvili, I. Mgaloblishvili, G. Tsitlanadze (2005). "<a href="http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2230.2004.01600.x?journalCode=ced" class="external text" title="http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2230.2004.01600.x?journalCode=ced" rel="nofollow">The use of a novel biodegradable preparation capable of the sustained release of bacteriophages and ciprofloxacin, in the complex treatment of multidrug-resistant Staphylococcus aureus-infected local radiation injuries caused by exposure to Sr90</a>". <i>Clinical &amp; Experimental Dermatology</i> <b>30</b>: 23. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1365-2230.2004.01600.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1365-2230.2004.01600.x" rel="nofollow">10.1111/j.1365-2230.2004.01600.x</a></span><span class="printonly">. <a href="http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2230.2004.01600.x?journalCode=ced" class="external free" title="http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2230.2004.01600.x?journalCode=ced" rel="nofollow">http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2230.2004.01600.x?journalCode=ced</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+use+of+a+novel+biodegradable+preparation+capable+of+the+sustained+release+of+bacteriophages+and+ciprofloxacin%2C+in+the+complex+treatment+of+multidrug-resistant+Staphylococcus+aureus-infected+local+radiation+injuries+++caused+by+exposure+to+Sr90&amp;rft.jtitle=Clinical+%26+Experimental+Dermatology&amp;rft.aulast=D.+Jikia%2C+N.+Chkhaidze%2C+E.+Imedashvili%2C+I.+Mgaloblishvili%2C+G.+Tsitlanadze&amp;rft.au=D.+Jikia%2C+N.+Chkhaidze%2C+E.+Imedashvili%2C+I.+Mgaloblishvili%2C+G.+Tsitlanadze&amp;rft.date=2005&amp;rft.volume=30&amp;rft.pages=23&amp;rft_id=info:doi/10.1111%2Fj.1365-2230.2004.01600.x&amp;rft_id=http%3A%2F%2Fwww.blackwell-synergy.com%2Fdoi%2Fabs%2F10.1111%2Fj.1365-2230.2004.01600.x%3FjournalCode%3Dced&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-32"><b><a href="#cite_ref-32" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWeber-Dabrowska_B.2C_Mulczyk_M.2C_G.C3.B3rski_A2003">Weber-Dabrowska B, Mulczyk M, Górski A (June 2003). "<a href="http://linkinghub.elsevier.com/retrieve/pii/S0041134503005256" class="external text" title="http://linkinghub.elsevier.com/retrieve/pii/S0041134503005256" rel="nofollow">Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man</a>". <i>Transplant. Proc.</i> <b>35</b> (4): 1385–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0041-1345%2803%2900525-6" class="external text" title="http://dx.doi.org/10.1016%2FS0041-1345%2803%2900525-6" rel="nofollow">10.1016/S0041-1345(03)00525-6</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12826166" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12826166">PMID 12826166</a><span class="printonly">. <a href="http://linkinghub.elsevier.com/retrieve/pii/S0041134503005256" class="external free" title="http://linkinghub.elsevier.com/retrieve/pii/S0041134503005256" rel="nofollow">http://linkinghub.elsevier.com/retrieve/pii/S0041134503005256</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bacteriophages+as+an+efficient+therapy+for+antibiotic-resistant+septicemia+in+man&amp;rft.jtitle=Transplant.+Proc.&amp;rft.aulast=Weber-Dabrowska+B%2C+Mulczyk+M%2C+G%C3%B3rski+A&amp;rft.au=Weber-Dabrowska+B%2C+Mulczyk+M%2C+G%C3%B3rski+A&amp;rft.date=June+2003&amp;rft.volume=35&amp;rft.issue=4&amp;rft.pages=1385%E2%80%936&amp;rft_id=info:doi/10.1016%2FS0041-1345%2803%2900525-6&amp;rft_id=info:pmid/12826166&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0041134503005256&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-33"><b><a href="#cite_ref-33" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMathur_MD.2C_Vidhani_S.2C_Mehndiratta_PL.2003">Mathur MD, Vidhani S, Mehndiratta PL. (2003). "Bacteriophage therapy: an alternative to conventional antibiotics". <i>J Assoc Physicians India</i> <b>51</b>: 593–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1258%2F095646202760159701" class="external text" title="http://dx.doi.org/10.1258%2F095646202760159701" rel="nofollow">10.1258/095646202760159701</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12194741" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12194741">PMID 12194741</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bacteriophage+therapy%3A+an+alternative+to+conventional+antibiotics&amp;rft.jtitle=J+Assoc+Physicians+India&amp;rft.aulast=Mathur+MD%2C+Vidhani+S%2C+Mehndiratta+PL.&amp;rft.au=Mathur+MD%2C+Vidhani+S%2C+Mehndiratta+PL.&amp;rft.date=2003&amp;rft.volume=51&amp;rft.pages=593%E2%80%936&amp;rft_id=info:doi/10.1258%2F095646202760159701&amp;rft_id=info:pmid/12194741&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-McGrath-34"><b><a href="#cite_ref-McGrath_34-0" title="">^</a></b> <cite style="font-style:normal" class="book" id="CITEREFMc_Grath_S_and_van_Sinderen_D_.28editors.29.2007">Mc Grath S and van Sinderen D (editors). (2007). <i><a href="http://www.horizonpress.com/phage" class="external text" title="http://www.horizonpress.com/phage" rel="nofollow">Bacteriophage: Genetics and Molecular Biology</a></i> (1st ed.). Caister Academic Press. <a href="http://www.horizonpress.com/phage" class="external text" title="http://www.horizonpress.com/phage" rel="nofollow">ISBN 978-1-904455-14-1</a> <span class="printonly">. <a href="http://www.horizonpress.com/phage" class="external free" title="http://www.horizonpress.com/phage" rel="nofollow">http://www.horizonpress.com/phage</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Bacteriophage%3A+Genetics+and+Molecular+Biology&amp;rft.aulast=Mc+Grath+S+and+van+Sinderen+D+%28editors%29.&amp;rft.au=Mc+Grath+S+and+van+Sinderen+D+%28editors%29.&amp;rft.date=2007&amp;rft.edition=1st&amp;rft.pub=Caister+Academic+Press&amp;rft_id=http%3A%2F%2Fwww.horizonpress.com%2Fphage&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-35"><b><a href="#cite_ref-35" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.idsociety.org/PrintFriendly.aspx?id=5558" class="external text" title="http://www.idsociety.org/PrintFriendly.aspx?id=5558" rel="nofollow">"Bad Bugs, No Drugs Executive Summary"</a>. Infectious Diseases Society of America<span class="printonly">. <a href="http://www.idsociety.org/PrintFriendly.aspx?id=5558" class="external free" title="http://www.idsociety.org/PrintFriendly.aspx?id=5558" rel="nofollow">http://www.idsociety.org/PrintFriendly.aspx?id=5558</a></span><span class="reference-accessdate">. Retrieved on 2007-12-11</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Bad+Bugs%2C+No+Drugs+Executive+Summary&amp;rft.atitle=&amp;rft.pub=Infectious+Diseases+Society+of+America&amp;rft_id=http%3A%2F%2Fwww.idsociety.org%2FPrintFriendly.aspx%3Fid%3D5558&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15831135-36"><b><a href="#cite_ref-pmid15831135_36-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWallace_RJ2004">Wallace RJ (2004). "Antimicrobial properties of plant secondary metabolites". <i>Proc Nutr Soc</i> <b>63</b> (4): 621–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1079%2FPNS2004393" class="external text" title="http://dx.doi.org/10.1079%2FPNS2004393" rel="nofollow">10.1079/PNS2004393</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15831135" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15831135">PMID 15831135</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Antimicrobial+properties+of+plant+secondary+metabolites&amp;rft.jtitle=Proc+Nutr+Soc&amp;rft.aulast=Wallace+RJ&amp;rft.au=Wallace+RJ&amp;rft.date=2004&amp;rft.volume=63&amp;rft.issue=4&amp;rft.pages=621%E2%80%939&amp;rft_id=info:doi/10.1079%2FPNS2004393&amp;rft_id=info:pmid/15831135&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12872531-37"><b><a href="#cite_ref-pmid12872531_37-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFThuille_N.2C_Fille_M.2C_Nagl_M2003">Thuille N, Fille M, Nagl M (2003). "Bactericidal activity of herbal extracts". <i>Int J Hyg Environ Health</i> <b>206</b> (3): 217–21. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1078%2F1438-4639-00217" class="external text" title="http://dx.doi.org/10.1078%2F1438-4639-00217" rel="nofollow">10.1078/1438-4639-00217</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12872531" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12872531">PMID 12872531</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bactericidal+activity+of+herbal+extracts&amp;rft.jtitle=Int+J+Hyg+Environ+Health&amp;rft.aulast=Thuille+N%2C+Fille+M%2C+Nagl+M&amp;rft.au=Thuille+N%2C+Fille+M%2C+Nagl+M&amp;rft.date=2003&amp;rft.volume=206&amp;rft.issue=3&amp;rft.pages=217%E2%80%9321&amp;rft_id=info:doi/10.1078%2F1438-4639-00217&amp;rft_id=info:pmid/12872531&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12410554-38"><b><a href="#cite_ref-pmid12410554_38-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSingh_G.2C_Kapoor_IP.2C_Pandey_SK.2C_Singh_UK.2C_Singh_RK2002">Singh G, Kapoor IP, Pandey SK, Singh UK, Singh RK (2002). "Studies on essential oils: part 10; antibacterial activity of volatile oils of some spices". <i>Phytother Res</i> <b>16</b> (7): 680–2. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fptr.951" class="external text" title="http://dx.doi.org/10.1002%2Fptr.951" rel="nofollow">10.1002/ptr.951</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12410554" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12410554">PMID 12410554</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Studies+on+essential+oils%3A+part+10%3B+antibacterial+activity+of+volatile+oils+of+some+spices&amp;rft.jtitle=Phytother+Res&amp;rft.aulast=Singh+G%2C+Kapoor+IP%2C+Pandey+SK%2C+Singh+UK%2C+Singh+RK&amp;rft.au=Singh+G%2C+Kapoor+IP%2C+Pandey+SK%2C+Singh+UK%2C+Singh+RK&amp;rft.date=2002&amp;rft.volume=16&amp;rft.issue=7&amp;rft.pages=680%E2%80%932&amp;rft_id=info:doi/10.1002%2Fptr.951&amp;rft_id=info:pmid/12410554&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10677479-39"><b><a href="#cite_ref-pmid10677479_39-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFStermitz_FR.2C_Lorenz_P.2C_Tawara_JN.2C_Zenewicz_LA.2C_Lewis_K2000">Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K (2000). "<a href="http://www.pnas.org/cgi/content/full/97/4/1433" class="external text" title="http://www.pnas.org/cgi/content/full/97/4/1433" rel="nofollow">Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor</a>". <i>Proc. Natl. Acad. Sci. U.S.A.</i> <b>97</b> (4): 1433–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1073%2Fpnas.030540597" class="external text" title="http://dx.doi.org/10.1073%2Fpnas.030540597" rel="nofollow">10.1073/pnas.030540597</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10677479" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10677479">PMID 10677479</a><span class="printonly">. <a href="http://www.pnas.org/cgi/content/full/97/4/1433" class="external free" title="http://www.pnas.org/cgi/content/full/97/4/1433" rel="nofollow">http://www.pnas.org/cgi/content/full/97/4/1433</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Synergy+in+a+medicinal+plant%3A+antimicrobial+action+of+berberine+potentiated+by+5%27-methoxyhydnocarpin%2C+a+multidrug+pump+inhibitor&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.aulast=Stermitz+FR%2C+Lorenz+P%2C+Tawara+JN%2C+Zenewicz+LA%2C+Lewis+K&amp;rft.au=Stermitz+FR%2C+Lorenz+P%2C+Tawara+JN%2C+Zenewicz+LA%2C+Lewis+K&amp;rft.date=2000&amp;rft.volume=97&amp;rft.issue=4&amp;rft.pages=1433%E2%80%937&amp;rft_id=info:doi/10.1073%2Fpnas.030540597&amp;rft_id=info:pmid/10677479&amp;rft_id=http%3A%2F%2Fwww.pnas.org%2Fcgi%2Fcontent%2Ffull%2F97%2F4%2F1433&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Shand-40"><b><a href="#cite_ref-Shand_40-0" title="">^</a></b> <cite style="font-style:normal" class="book" id="CITEREFShand_RF.3B_Leyva_KJ2008">Shand RF; Leyva KJ (2008). <a href="http://www.horizonpress.com/arch" class="external text" title="http://www.horizonpress.com/arch" rel="nofollow">"Archaeal Antimicrobials: An Undiscovered Country"</a>. <i>Archaea: New Models for Prokaryotic Biology</i>. Caister Academic Press. <a href="http://www.horizonpress.com/arch" class="external text" title="http://www.horizonpress.com/arch" rel="nofollow">ISBN 978-1-904455-27-1</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Archaeal+Antimicrobials%3A+An+Undiscovered+Country&amp;rft.atitle=Archaea%3A+New+Models+for+Prokaryotic+Biology&amp;rft.aulast=Shand+RF%3B+Leyva+KJ&amp;rft.au=Shand+RF%3B+Leyva+KJ&amp;rft.date=2008&amp;rft.pub=Caister+Academic+Press&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-41"><b><a href="#cite_ref-41" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBelogurov_GA.2C_Vassylyeva_MN.2C_Sevostyanova_A.2C_Appleman_JR.2C_Xiang_AX.2C_et_al.">Belogurov GA, Vassylyeva MN, Sevostyanova A, Appleman JR, Xiang AX, et al. (<span class="mw-formatted-date" title="2008-10-22"><a href="/wiki/2008" title="2008">2008</a>-<a href="/wiki/October_22" title="October 22">10-22</a></span>). "Transcription inactivation through local refolding of the RNA polymerase structure.". <i>Nature</i> <b>457</b>: 332. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1038%2Fnature07510" class="external text" title="http://dx.doi.org/10.1038%2Fnature07510" rel="nofollow">10.1038/nature07510</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Transcription+inactivation+through+local+refolding+of+the+RNA+polymerase+structure.&amp;rft.jtitle=Nature&amp;rft.aulast=Belogurov+GA%2C+Vassylyeva+MN%2C+Sevostyanova+A%2C+Appleman+JR%2C+Xiang+AX%2C+et+al.&amp;rft.au=Belogurov+GA%2C+Vassylyeva+MN%2C+Sevostyanova+A%2C+Appleman+JR%2C+Xiang+AX%2C+et+al.&amp;rft.date=%5B%5B2008-10-22%5D%5D&amp;rft.volume=457&amp;rft.pages=332&amp;rft_id=info:doi/10.1038%2Fnature07510&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-42"><b><a href="#cite_ref-42" title="">^</a></b> <a href="http://newswise.com/articles/view/545646/" class="external text" title="http://newswise.com/articles/view/545646/" rel="nofollow">Researchers Find Clue to Antibiotic Resistance</a> Newswise, Retrieved on <span class="mw-formatted-date" title="2008-10-22"><span class="mw-formatted-date" title="10-22"><a href="/wiki/October_22" title="October 22">October 22</a></span>, <a href="/wiki/2008" title="2008">2008</a></span>.</li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Antibiotic_resistance&amp;action=edit&amp;section=18" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.antibiotic-resistance.org" class="external text" title="http://www.antibiotic-resistance.org" rel="nofollow">The History Cause and Treatment of Antibiotic Resistant Infections</a></li>
<li><a href="http://www.cdc.gov/ncidod/dhqp/ar_mrsa_spotlight_2006.html" class="external text" title="http://www.cdc.gov/ncidod/dhqp/ar_mrsa_spotlight_2006.html" rel="nofollow">CDC Article on Hospital Acquired MRSA</a></li>
<li><a href="http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca.html" class="external text" title="http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca.html" rel="nofollow">CDC Article on Community Acquired MRSA</a></li>
<li><a href="http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf" class="external text" title="http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf" rel="nofollow">CDC Guideline "Management of Multidrug-Resistant Organisms in Healthcare Settings, 2006"</a></li>
<li><a href="http://www.reactgroup.org/" class="external text" title="http://www.reactgroup.org/" rel="nofollow">ReAct Action on Antibiotic Resistance</a></li>
<li><a href="http://www.cc.nih.gov/hes/vre.html" class="external text" title="http://www.cc.nih.gov/hes/vre.html" rel="nofollow">Vancomycin Resistant Enterococcus—Guidelines for Healthcare Workers</a></li>
<li><a href="http://antibiotic.org" class="external text" title="http://antibiotic.org" rel="nofollow">Alliance for the Prudent Use of Antibiotics</a></li>
<li><cite style="font-style:normal" class="" id="CITEREFCox_LA.2C_Popken_DA2006">Cox LA, Popken DA (February 2006). "Quantifying potential human health impacts of animal antibiotic use: enrofloxacin and macrolides in chickens". <i>Risk Anal.</i> <b>26</b> (1): 135–46. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1539-6924.2006.00723.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1539-6924.2006.00723.x" rel="nofollow">10.1111/j.1539-6924.2006.00723.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16492187" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16492187">PMID 16492187</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Quantifying+potential+human+health+impacts+of+animal+antibiotic+use%3A+enrofloxacin+and+macrolides+in+chickens&amp;rft.jtitle=Risk+Anal.&amp;rft.aulast=Cox+LA%2C+Popken+DA&amp;rft.au=Cox+LA%2C+Popken+DA&amp;rft.date=February+2006&amp;rft.volume=26&amp;rft.issue=1&amp;rft.pages=135%E2%80%9346&amp;rft_id=info:doi/10.1111%2Fj.1539-6924.2006.00723.x&amp;rft_id=info:pmid/16492187&amp;rfr_id=info:sid/en.wikipedia.org:Antibiotic_resistance"><span style="display: none;">&#160;</span></span></li>
<li><a href="http://www.safecarecampaign.org/new_guide/antibiotics/antibiotics_01.html" class="external text" title="http://www.safecarecampaign.org/new_guide/antibiotics/antibiotics_01.html" rel="nofollow">Prudent Use of Antibiotics</a></li>
<li><a href="http://www.bacteriophagetherapy.info" class="external text" title="http://www.bacteriophagetherapy.info" rel="nofollow">Information about phage therapy – a possible alternative to antibiotics in case of resistant infections</a></li>
<li><a href="http://www.gmo-safety.eu/en/gene_transfer/44.docu.html" class="external text" title="http://www.gmo-safety.eu/en/gene_transfer/44.docu.html" rel="nofollow">Antibiotic-resistance genes as markers</a> Once necessary, now undesirable</li>
<li><a href="http://cbs5.com/health/local_story_025195614.html" class="external text" title="http://cbs5.com/health/local_story_025195614.html" rel="nofollow">CBS Article on Phage Therapy and Antibiotic Resistance</a></li>
<li><a href="http://knowledge.allianz.com/en/globalissues/safety_security/health_pandemics/hospital_infections_mrsa.html" class="external text" title="http://knowledge.allianz.com/en/globalissues/safety_security/health_pandemics/hospital_infections_mrsa.html" rel="nofollow">Hospitals: Breeding the Superbug?</a> Article on MRSA infections in hospitals, Allianz Knowledge, May 2008</li>
<li><a href="http://www.eu-burden.info/burden/pages/home.php" class="external text" title="http://www.eu-burden.info/burden/pages/home.php" rel="nofollow">BURDEN of Resistance and Disease in European Nations - An EU-Project to estimate the financial burden of antibiotic resistance in European Hospitals</a></li>
<li><a href="http://www.extendingthecure.org" class="external text" title="http://www.extendingthecure.org" rel="nofollow">Extending the Cure: Policy Research to Extend Antibiotic Effectiveness</a></li>
<li><a href="http://www.fda.gov/oc/antimicrobial/questions.html" class="external text" title="http://www.fda.gov/oc/antimicrobial/questions.html" rel="nofollow">2003 New Guidance for Industry on Antimicrobial Drugs for Food Animals Questions and Answers, U.S. FDA</a></li>
<li><a href="http://www.scidev.net/en/health/antibiotic-resistance/" class="external text" title="http://www.scidev.net/en/health/antibiotic-resistance/" rel="nofollow">SciDev.net Antibiotic Resistance spotlight</a> The Science and Development Network is an online science and development network focused on news and information important to the developing world</li>
<li><a href="http://www.dobugsneeddrugs.org/" class="external text" title="http://www.dobugsneeddrugs.org/" rel="nofollow">Do Bugs Need Drugs?</a></li>
</ul>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";background:#efefef" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;background:#efefef;border:none;; font-size:xx-small;"><a href="/wiki/Template:Pharmacology" title="Template:Pharmacology"><span title="View this template" style=";background:#efefef;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/w/index.php?title=Template_talk:Pharmacology&amp;action=edit&amp;redlink=1" class="new" title="Template talk:Pharmacology (page does not exist)"><span title="Discussion about this template" style=";background:#efefef;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Pharmacology&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Pharmacology&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";background:#efefef;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Medication" title="Medication" class="mw-redirect">Medication</a> &gt; <a href="/wiki/Pharmacology" title="Pharmacology">Pharmacology</a></span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;"><a href="/wiki/Pharmacokinetics" title="Pharmacokinetics">Pharmacokinetics</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/ADME" title="ADME">ADME</a>: <a href="/wiki/Absorption_(pharmacokinetics)" title="Absorption (pharmacokinetics)">Absorption</a>&#160;· <a href="/wiki/Distribution_(pharmacology)" title="Distribution (pharmacology)">Distribution</a>&#160;· <a href="/wiki/Drug_metabolism" title="Drug metabolism">Metabolism</a>&#160;· <a href="/wiki/Excretion" title="Excretion">Excretion</a> (<a href="/wiki/Clearance_(medicine)" title="Clearance (medicine)">Clearance</a>)
<p><a href="/wiki/Loading_dose" title="Loading dose">Loading dose</a>&#160;· <a href="/wiki/Volume_of_distribution" title="Volume of distribution">Volume of distribution</a> (<a href="/wiki/Initial_volume_of_distribution" title="Initial volume of distribution">Initial</a>)&#160;· <a href="/wiki/Rate_of_infusion" title="Rate of infusion">Rate of infusion</a></p>
<p><a href="/wiki/Compartment_(pharmacokinetics)" title="Compartment (pharmacokinetics)">Compartment</a> · <a href="/wiki/Bioequivalence" title="Bioequivalence">Bioequivalence</a> · <a href="/wiki/Bioavailability" title="Bioavailability">Bioavailability</a></p>
<p><a href="/wiki/Biological_half-life" title="Biological half-life">Biological half-life</a> · <a href="/wiki/Plasma_protein_binding" title="Plasma protein binding">Plasma protein binding</a></p>
<p><a href="/wiki/Phase_1_reaction" title="Phase 1 reaction">Phase 1 reaction</a> · <a href="/wiki/Phase_2_reaction" title="Phase 2 reaction">Phase 2 reaction</a></p>
<a href="/wiki/Therapeutic_index" title="Therapeutic index">Therapeutic index</a> (<a href="/wiki/Median_lethal_dose" title="Median lethal dose">LD50</a>/<a href="/wiki/Effective_dose" title="Effective dose">ED50</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;"><a href="/wiki/Pharmacodynamics" title="Pharmacodynamics">Pharmacodynamics</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Toxicity" title="Toxicity">Toxicity</a> (<a href="/wiki/Neurotoxicology" title="Neurotoxicology" class="mw-redirect">Neurotoxicology</a>)&#160;· <a href="/wiki/Dose-response_relationship" title="Dose-response relationship">Dose-response relationship</a> (<a href="/wiki/Efficacy#Pharmacology" title="Efficacy">Efficacy</a>, <a href="/wiki/Potency_(pharmacology)" title="Potency (pharmacology)">Potency</a>)<br />
<a href="/wiki/Antimicrobial_pharmacodynamics" title="Antimicrobial pharmacodynamics">Antimicrobial pharmacodynamics</a>: <a href="/wiki/Minimum_inhibitory_concentration" title="Minimum inhibitory concentration">Minimum inhibitory concentration</a>/<a href="/wiki/Bacteriostatic_agent" title="Bacteriostatic agent">Bacteriostatic</a> · <a href="/wiki/Minimum_bactericidal_concentration" title="Minimum bactericidal concentration">Minimum bactericidal concentration</a>/<a href="/wiki/Bactericide" title="Bactericide">Bactericide</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;">Agonism and antagonism</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Agonist" title="Agonist">Agonist</a>: <a href="/wiki/Inverse_agonist" title="Inverse agonist">Inverse agonist</a> · <a href="/wiki/Physiological_agonism_and_antagonism" title="Physiological agonism and antagonism">Physiological agonist</a> · <a href="/wiki/Partial_agonist" title="Partial agonist">Partial agonist</a><br />
<a href="/wiki/Receptor_antagonist" title="Receptor antagonist">Antagonist</a>: <a href="/wiki/Competitive_antagonist" title="Competitive antagonist">Competitive antagonist</a> · <a href="/wiki/Physiological_agonism_and_antagonism" title="Physiological agonism and antagonism">Physiological antagonist</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;">Other</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Drug_tolerance" title="Drug tolerance">Drug tolerance</a>: <a href="/wiki/Tachyphylaxis" title="Tachyphylaxis">Tachyphylaxis</a><br />
<a href="/wiki/Drug_resistance" title="Drug resistance">Drug resistance</a>: <strong class="selflink">Antibiotic resistance</strong> · <a href="/wiki/Multiple_drug_resistance" title="Multiple drug resistance">Multiple drug resistance</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;">Related fields/subfields</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Pharmacogenetics" title="Pharmacogenetics">pharmacogenetics</a>&#160;· <a href="/wiki/Pharmacogenomics" title="Pharmacogenomics">pharmacogenomics</a>&#160;· <a href="/wiki/Neuropsychopharmacology" title="Neuropsychopharmacology">Neuropsychopharmacology</a> (<a href="/wiki/Neuropharmacology" title="Neuropharmacology">Neuropharmacology</a>, <a href="/wiki/Psychopharmacology" title="Psychopharmacology">Psychopharmacology</a>)</div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Preprocessor node count: 18932/1000000
Post-expand include size: 186534/2048000 bytes
Template argument size: 69516/2048000 bytes
Expensive parser function count: 9/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:1914-0!1!0!default!!en!2 and timestamp 20090404033813 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Antibiotic_resistance">http://en.wikipedia.org/wiki/Antibiotic_resistance</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Antibiotics" title="Category:Antibiotics">Antibiotics</a></span> | <span dir='ltr'><a href="/wiki/Category:Medical_disasters" title="Category:Medical disasters">Medical disasters</a></span> | <span dir='ltr'><a href="/wiki/Category:Pharmaceuticals_policy" title="Category:Pharmaceuticals policy">Pharmaceuticals policy</a></span> | <span dir='ltr'><a href="/wiki/Category:Veterinary_medicine" title="Category:Veterinary medicine">Veterinary medicine</a></span></div><div id="mw-hidden-catlinks" class="mw-hidden-cats-hidden">Hidden categories:&#32;<span dir='ltr'><a href="/wiki/Category:All_articles_with_dead_external_links" title="Category:All articles with dead external links">All articles with dead external links</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_dead_external_links_since_June_2008" title="Category:Articles with dead external links since June 2008">Articles with dead external links since June 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_July_2008" title="Category:Articles with unsourced statements since July 2008">Articles with unsourced statements since July 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_needing_more_viewpoints" title="Category:Articles needing more viewpoints">Articles needing more viewpoints</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_March_2008" title="Category:Articles with unsourced statements since March 2008">Articles with unsourced statements since March 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_December_2008" title="Category:Articles with unsourced statements since December 2008">Articles with unsourced statements since December 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_needing_additional_references_from_January_2008" title="Category:Articles needing additional references from January 2008">Articles needing additional references from January 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_February_2007" title="Category:Articles with unsourced statements since February 2007">Articles with unsourced statements since February 2007</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Antibiotic_resistance" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Antibiotic_resistance" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=Antibiotic_resistance&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Antibiotic_resistance&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Antibiotic_resistance" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Antibiotic_resistance" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Antibiotic_resistance" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Antibiotic_resistance&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Antibiotic_resistance&amp;oldid=281630346" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Antibiotic_resistance&amp;id=281630346">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-ar"><a href="http://ar.wikipedia.org/wiki/%D9%85%D9%82%D8%A7%D9%88%D9%85%D8%A9_%D8%A7%D9%84%D9%85%D8%B6%D8%A7%D8%AF%D8%A7%D8%AA_%D8%A7%D9%84%D8%AD%D9%8A%D9%88%D9%8A%D8%A9">العربية</a></li>
				<li class="interwiki-cs"><a href="http://cs.wikipedia.org/wiki/Antibiotick%C3%A1_rezistence">Česky</a></li>
				<li class="interwiki-da"><a href="http://da.wikipedia.org/wiki/Antibiotikaresistens">Dansk</a></li>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/Antibiotikum-Resistenz">Deutsch</a></li>
				<li class="interwiki-es"><a href="http://es.wikipedia.org/wiki/Resistencia_a_antibi%C3%B3ticos">Español</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/R%C3%A9sistance_aux_antibiotiques">Français</a></li>
				<li class="interwiki-it"><a href="http://it.wikipedia.org/wiki/Resistenza_agli_antibiotici">Italiano</a></li>
				<li class="interwiki-he"><a href="http://he.wikipedia.org/wiki/%D7%A2%D7%9E%D7%99%D7%93%D7%95%D7%AA_%D7%9C%D7%90%D7%A0%D7%98%D7%99%D7%91%D7%99%D7%95%D7%98%D7%99%D7%A7%D7%94">עברית</a></li>
				<li class="interwiki-hu"><a href="http://hu.wikipedia.org/wiki/Antibiotikum-ellen%C3%A1ll%C3%A1s">Magyar</a></li>
				<li class="interwiki-nl"><a href="http://nl.wikipedia.org/wiki/Resistentie_tegen_antibiotica">Nederlands</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikipedia.org/wiki/Oporno%C5%9B%C4%87_na_antybiotyki">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikipedia.org/wiki/Resist%C3%AAncia_antibi%C3%B3tica">Português</a></li>
				<li class="interwiki-ro"><a href="http://ro.wikipedia.org/wiki/Rezisten%C5%A3a_la_antibiotice">Română</a></li>
				<li class="interwiki-fi"><a href="http://fi.wikipedia.org/wiki/Antibioottiresistenssi">Suomi</a></li>
				<li class="interwiki-sv"><a href="http://sv.wikipedia.org/wiki/Antibiotikaresistens">Svenska</a></li>
				<li class="interwiki-uk"><a href="http://uk.wikipedia.org/wiki/%D0%A0%D0%B5%D0%B7%D0%B8%D1%81%D1%82%D0%B5%D0%BD%D1%82%D0%BD%D1%96%D1%81%D1%82%D1%8C">Українська</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 4 April 2009, at 03:38.</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv84 in 0.076 secs. --></body></html>
